Term,Overlap,P.value,Adjusted.P.value,Old.P.value,Old.Adjusted.P.value,Odds.Ratio,Combined.Score,Genes
Defense Response To Virus (GO:0051607),21/189,4.14652778397336e-23,2.82793194866983e-20,0,0,32.8933333333333,1695.22983267971,IFITM3;GBP5;IFITM1;RSAD2;STAT1;MX2;EIF2AK2;DDX60L;IFIT1;DDX60;USP18;IFIT3;IFI44L;PML;IFIT2;IFIH1;CXCL10;IFI27;OAS2;OAS3;RIGI
Defense Response To Symbiont (GO:0140546),18/148,1.28118734948504e-20,4.36884886174399e-18,0,0,35.101775147929,1607.79871101336,IFITM3;GBP5;IFITM1;RSAD2;STAT1;MX2;EIF2AK2;DDX60L;IFIT1;DDX60;IFIT3;IFI44L;IFIT2;IFIH1;IFI27;OAS2;OAS3;RIGI
Negative Regulation Of Viral Process (GO:0048525),10/61,2.95696527737383e-13,6.72216773056317e-11,0,0,45.2644778841769,1305.85496154656,IFITM3;IFIH1;IFITM1;RSAD2;OAS2;STAT1;OAS3;TRIM14;EIF2AK2;IFIT1
Regulation Of Viral Genome Replication (GO:0045069),9/67,3.13390518962764e-11,5.34330834831512e-09,0,0,35.397146254459,856.120905925234,IFITM3;IFIH1;IFITM1;RSAD2;OAS2;OAS3;EIF2AK2;ADARB1;IFIT1
Antiviral Innate Immune Response (GO:0140374),8/46,4.70059981906607e-11,6.41161815320613e-09,0,0,47.5263157894737,1130.21123941363,IFIH1;CXCL10;EIF2AK2;IFIT1;USP18;IFIT3;IFIT2;RIGI
Negative Regulation Of Viral Genome Replication (GO:0045071),8/53,1.55350312697728e-10,1.76581522099751e-08,0,0,40.1191919191919,906.105528526788,IFITM3;IFIH1;IFITM1;RSAD2;OAS2;OAS3;EIF2AK2;IFIT1
Cellular Response To Type I Interferon (GO:0071357),6/38,2.54589234864338e-08,2.48042654539255e-06,0,0,41.4,723.928660428354,IFITM3;IFITM1;IFI27;STAT1;OAS2;IFIT1
Positive Regulation Of Defense Response To Virus By Host (GO:0002230),5/28,2.06513475959943e-07,1.76052738255852e-05,0,0,47.494027711419,731.070827128061,DTX3L;STAT1;PARP9;TRIM22;RIGI
Regulation Of Defense Response To Virus By Host (GO:0050691),5/37,8.85218957453941e-07,6.03719328983588e-05,0,0,34.1208791208791,475.557392025535,DTX3L;STAT1;PARP9;TRIM22;RIGI
Type I Interferon-Mediated Signaling Pathway (GO:0060337),5/37,8.85218957453941e-07,6.03719328983588e-05,0,0,34.1208791208791,475.557392025535,IFITM3;IFITM1;IFI27;STAT1;OAS2
Response To Interferon-Alpha (GO:0035455),4/17,1.13070325335394e-06,7.01036017079443e-05,0,0,66.5250836120401,910.906067894117,IFITM3;IFITM1;MX2;EIF2AK2
Response To Type II Interferon (GO:0034341),6/80,2.35683049297221e-06,0.000124061608806046,0,0,17.8648648648649,231.496364212191,IFITM3;GBP5;IFITM1;STAT1;CCL2;GBP4
Response To Cytokine (GO:0034097),7/125,2.36481072504193e-06,0.000124061608806046,0,0,13.188154637212,170.850071481362,IFITM3;IFITM1;STAT1;MX2;EIF2AK2;XAF1;PML
Interferon-Mediated Signaling Pathway (GO:0140888),5/49,3.70038052945878e-06,0.000180261394363635,0,0,24.8001998001998,310.17795638157,IFITM3;IFITM1;IFI27;OAS2;STAT1
Response To Interferon-Beta (GO:0035456),4/29,1.07966236629648e-05,0.000490886489209468,0,0,34.5721739130435,395.376960698322,IFITM3;IFITM1;STAT1;XAF1
Positive Regulation Of Type I Interferon Production (GO:0032481),5/64,1.39789215268878e-05,0.000595851530083594,0,0,18.4810951760104,206.580942044715,IFIH1;OAS2;STAT1;OAS3;RIGI
Positive Regulation Of Interferon-Beta Production (GO:0032728),4/36,2.60968338566516e-05,0.00104694357001391,0,0,27,284.949807097545,IFIH1;OAS2;OAS3;RIGI
Cellular Response To Exogenous dsRNA (GO:0071360),3/14,3.75406132297874e-05,0.00142237212348417,0,0,58.3372434017595,594.461596779736,IFIH1;IFIT1;RIGI
Regulation Of Response To Cytokine Stimulus (GO:0060759),3/16,5.73537173328344e-05,0.0019914847327283,0,0,49.3573200992556,482.037057609759,IFIH1;PARP9;RIGI
Regulation Of Viral Entry Into Host Cell (GO:0046596),4/44,5.84013118102141e-05,0.0019914847327283,0,0,21.5913043478261,210.475752932146,IFITM3;IFITM1;TRIM22;LY6E
Cellular Response To dsRNA (GO:0071359),3/17,6.94016149133282e-05,0.00225390006528047,0,0,45.8294930875576,438.844913306996,IFIH1;IFIT1;RIGI
Negative Regulation Of Viral Entry Into Host Cell (GO:0046597),3/18,8.2992372390902e-05,0.00257276354411796,0,0,42.7720430107527,401.918702150952,IFITM3;IFITM1;LY6E
Regulation Of Interferon-Beta Production (GO:0032648),4/50,9.6920100106146e-05,0.00287389166401702,0,0,18.7693761814745,173.459510422979,IFIH1;OAS2;OAS3;RIGI
Negative Regulation Of Viral Life Cycle (GO:1903901),3/20,0.000115140558402798,0.00327191086794617,0,0,37.7362428842505,342.243455875041,IFITM3;IFITM1;LY6E
Positive Regulation Of Interferon-Alpha Production (GO:0032727),3/21,0.000133863826694384,0.0036518051922228,0,0,35.6379928315412,317.844120956984,IFIH1;STAT1;RIGI
Cytosolic Pattern Recognition Receptor Signaling Pathway (GO:0002753),3/23,0.000177013822442328,0.00464320872714107,0,0,32.0709677419355,277.070157925125,IFIH1;OAS3;RIGI
Interleukin-27-Mediated Signaling Pathway (GO:0070106),2/5,0.000225867685995685,0.00550149149460917,0,0,141.141843971631,1184.9649875808,OAS2;STAT1
Regulation Of Ribonuclease Activity (GO:0060700),2/5,0.000225867685995685,0.00550149149460917,0,0,141.141843971631,1184.9649875808,OAS2;OAS3
Cytokine-Mediated Signaling Pathway (GO:0019221),7/257,0.00024024912531664,0.0056499966712396,0,0,6.1832808988764,51.5304375193057,CXCL10;CXCL9;OAS2;STAT1;IL31RA;CCL2;BIRC3
Regulation Of Interferon-Alpha Production (GO:0032647),3/26,0.000257175471745071,0.00584645572433795,0,0,27.8835904628331,230.478841867914,IFIH1;STAT1;RIGI
Cellular Response To Type II Interferon (GO:0071346),4/66,0.000286039831100209,0.0062928762842046,0,0,13.914446002805,113.53324529188,GBP5;STAT1;CCL2;GBP4
RIG-I Signaling Pathway (GO:0039529),2/6,0.000337742018204385,0.0069800017095573,0,0,105.851063829787,846.091709850458,OAS3;RIGI
Regulation Of Nuclease Activity (GO:0032069),2/6,0.000337742018204385,0.0069800017095573,0,0,105.851063829787,846.091709850458,OAS2;OAS3
Positive Regulation Of Apoptotic Cell Clearance (GO:2000427),2/7,0.00047136037144685,0.00945493450961033,0,0,84.6765957446809,648.61320885898,CCL2;C2
Positive Regulation Of Tumor Necrosis Factor Production (GO:0032760),4/78,0.000541808500386598,0.0105575256361046,0,0,11.6509988249119,87.6224777531497,IFIH1;OAS2;OAS3;RIGI
Positive Regulation Of Chromatin Binding (GO:0035563),2/8,0.000626515812358611,0.0115655565214134,0,0,70.5602836879433,520.405838891401,DTX3L;PARP9
Response To Exogenous dsRNA (GO:0043330),3/35,0.000627456878727705,0.0115655565214134,0,0,20.0322580645161,147.714577834362,IFIH1;IFIT1;RIGI
Positive Regulation Of Tumor Necrosis Factor Superfamily Cytokine Production (GO:1903557),4/82,0.000654716736194525,0.0117504424759123,0,0,11.0512820512821,81.0203511832808,IFIH1;OAS2;OAS3;RIGI
Regulation Of Chromatin Binding (GO:0035561),2/10,0.00100061743308299,0.017497976650323,0,0,52.9148936170213,365.490474395909,DTX3L;PARP9
Protein Ubiquitination (GO:0016567),8/434,0.00115586779244925,0.0197075458612597,0,0,4.15663679043961,28.1109350847384,HERC5;RNF144A;RNF213;DTX3L;TRIM14;BRCA2;TRIM22;HERC6
Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060334),2/11,0.00121915693339518,0.0202796348433051,0,0,47.0330969267139,315.57306477086,PARP14;PARP9
Negative Regulation Of Viral Transcription (GO:0032897),2/13,0.00171820728195121,0.0279004134831126,0,0,38.4777562862669,244.967627650286,IFITM3;TRIM14
Blood Circulation (GO:0008015),3/50,0.00178380280651807,0.0282919421871005,0,0,13.6286890871654,86.2560793374205,CXCL10;STAT1;SERPING1
Protein Modification By Small Protein Conjugation (GO:0032446),7/364,0.00186007539767306,0.0288311686639324,0,0,4.3064551663362,27.0752790227087,IFIH1;HERC5;RNF144A;RNF213;TRIM14;PML;HERC6
Ubiquitin-Dependent Protein Catabolic Process (GO:0006511),7/367,0.0019483064146077,0.0289968979918902,0,0,4.26991260923845,26.6476483616696,HERC5;RNF144A;RNF213;DTX3L;IFI27;PML;HERC6
Negative Regulation Of Innate Immune Response (GO:0045824),3/52,0.00199745525261446,0.0289968979918902,0,0,13.0710994075049,81.2484021457959,OAS3;SERPING1;USP18
Positive Regulation Of Response To Cytokine Stimulus (GO:0060760),2/14,0.00199831994958774,0.0289968979918902,0,0,35.2695035460993,219.215782087706,IFIH1;RIGI
Negative Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060339),2/15,0.00229856115776933,0.0313814764002939,0,0,32.5548281505728,197.785944790075,OAS3;USP18
Defense Response To Protozoan (GO:0042832),2/15,0.00229856115776933,0.0313814764002939,0,0,32.5548281505728,197.785944790075,BATF2;GBP4
Modification-Dependent Protein Catabolic Process (GO:0019941),5/192,0.00233598333232967,0.0313814764002939,0,0,5.79332432273609,35.1036195447708,HERC5;RNF144A;RNF213;DTX3L;HERC6
Positive Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042531),3/55,0.00234670864576978,0.0313814764002939,0,0,12.3151364764268,74.5649680105793,IL31RA;PARP9;PARP14
Chemokine-Mediated Signaling Pathway (GO:0070098),3/57,0.00259925873279609,0.0336976882142846,0,0,11.857825567503,70.5840502992192,CXCL10;CXCL9;CCL2
Regulation Of Nucleocytoplasmic Transport (GO:0046822),2/16,0.00261873530111009,0.0336976882142846,0,0,30.2279635258359,179.707171319786,IFI27;MX2
Cellular Response To Chemokine (GO:1990869),3/59,0.00286798662253983,0.0355630341194938,0,0,11.4331797235023,66.9314921484465,CXCL10;CXCL9;CCL2
Negative Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001960),3/59,0.00286798662253983,0.0355630341194938,0,0,11.4331797235023,66.9314921484465,OAS3;PARP14;USP18
Regulation Of Viral Transcription (GO:0046782),2/17,0.00295864815409323,0.0360321078766353,0,0,28.2113475177305,164.275320369266,IFITM3;TRIM14
Regulation Of Tumor Necrosis Factor Production (GO:0032680),4/127,0.00328358624330666,0.0390163599924935,0,0,6.99222340049487,39.9872606434196,IFIH1;OAS2;OAS3;RIGI
Regulation Of RIG-I Signaling Pathway (GO:0039535),2/18,0.0033181068615317,0.0390163599924935,0,0,26.4468085106383,150.967927132668,DDX60;BIRC3
Cellular Response To Cytokine Stimulus (GO:0071345),6/308,0.00369545125333463,0.0427169110978681,0,0,4.32715231788079,24.2348769084832,GBP5;STAT1;IL31RA;CCL2;IFIT1;GBP4
Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042509),3/65,0.0037744923935292,0.0429033968731152,0,0,10.3236212278876,57.6005349072305,IL31RA;PARP9;PARP14
Neutrophil Chemotaxis (GO:0030593),3/70,0.00464934015982711,0.051537856540383,0,0,9.55079441502167,51.2976030457789,CXCL10;CXCL9;CCL2
Protein Polyubiquitination (GO:0000209),5/226,0.00468525968548937,0.051537856540383,0,0,4.8935905723236,26.2459603839384,RNF144A;RNF213;DTX3L;IFI27;TRIM22
Protein Autoubiquitination (GO:0051865),3/71,0.00483775444800633,0.0523706116434971,0,0,9.40986717267552,50.1668683589217,RNF213;DTX3L;BRCA2
Granulocyte Chemotaxis (GO:0071621),3/73,0.00522828338219596,0.0557138947915257,0,0,9.14009216589862,48.0190488484853,CXCL10;CXCL9;CCL2
Inflammatory Response (GO:0006954),5/236,0.00561521575546201,0.0589165714650014,0,0,4.67936825079682,24.2497743498507,CXCL10;CXCL9;BLNK;CCL2;SIGLEC1
Positive Regulation Of Response To Stimulus (GO:0048584),3/77,0.00606497387222347,0.0608281203067118,0,0,8.64428945074106,44.1310429963081,IFIH1;RSAD2;RIGI
Neutrophil Migration (GO:1990266),3/77,0.00606497387222347,0.0608281203067118,0,0,8.64428945074106,44.1310429963081,CXCL10;CXCL9;CCL2
Negative Regulation Of Blood Vessel Morphogenesis (GO:2000181),3/77,0.00606497387222347,0.0608281203067118,0,0,8.64428945074106,44.1310429963081,CXCL10;STAT1;PML
Regulation Of Innate Immune Response (GO:0045088),3/78,0.00628590121169597,0.0621302119764732,0,0,8.52860215053764,43.2352885381103,GBP5;PARP9;BIRC3
Negative Regulation Of Catalytic Activity (GO:0043086),2/26,0.00687473039677018,0.0669795161513895,0,0,17.6241134751773,87.7663729451488,IFIT1;PARP9
Negative Regulation Of Angiogenesis (GO:0016525),3/86,0.00822657379339773,0.0790214553112289,0,0,7.70345899727944,36.9795740873159,CXCL10;STAT1;PML
Integrated Stress Response Signaling (GO:0140467),2/29,0.00850836959509497,0.0791806876868636,0,0,15.6635145784082,74.6633523452467,BATF2;EIF2AK2
Positive Regulation Of Viral Genome Replication (GO:0045070),2/29,0.00850836959509497,0.0791806876868636,0,0,15.6635145784082,74.6633523452467,ADARB1;IFIT1
Regulation Of Cytokine Production (GO:0001817),4/167,0.00859145291616995,0.0791806876868636,0,0,5.26567084555882,25.0487299537183,IFIH1;EIF2AK2;IGF2BP3;RIGI
Double-Strand Break Repair (GO:0006302),4/168,0.00876926721113071,0.0797418698398819,0,0,5.23329798515376,24.787526542849,DTX3L;FSCN1;BRCA2;PARP9
Regulation Of Response To Biotic Stimulus (GO:0002831),2/31,0.00968443709523493,0.0857764428435094,0,0,14.5818048422597,67.6192573103848,HERC5;BIRC3
Receptor Signaling Pathway Via STAT (GO:0097696),2/31,0.00968443709523493,0.0857764428435094,0,0,14.5818048422597,67.6192573103848,STAT1;IL31RA
Positive Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051281),2/33,0.0109284466127731,0.0931650073738903,0,0,13.6396705559369,61.602018620944,CXCL10;CXCL9
Regulation Of Type I Interferon-Mediated Signaling Pathway (GO:0060338),2/33,0.0109284466127731,0.0931650073738903,0,0,13.6396705559369,61.602018620944,OAS3;USP18
Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900225),2/33,0.0109284466127731,0.0931650073738903,0,0,13.6396705559369,61.602018620944,GBP5;EIF2AK2
Regulation Of Cell Population Proliferation (GO:0042127),9/766,0.0113020796523986,0.0949219969000229,0,0,2.6165444358402,11.7293630547546,CXCL10;CXCL9;IFITM1;STAT1;IL31RA;EIF2AK2;ADARB1;IFIT3;PML
Regulation Of Defense Response (GO:0031347),3/97,0.0114129087181846,0.0949219969000229,0,0,6.79821551132464,30.408487463309,HERC5;USP18;BIRC3
DNA Damage Checkpoint Signaling (GO:0000077),2/34,0.0115754972109367,0.095114326480227,0,0,13.2127659574468,58.9139360386718,DTX3L;PARP9
Receptor Signaling Pathway Via JAK-STAT (GO:0007259),2/36,0.0129188360685873,0.10488864522353,0,0,12.4342928660826,54.0775960524003,STAT1;IL31RA
Negative Regulation Of Endothelial Cell Proliferation (GO:0001937),2/37,0.0136147863977475,0.109238639097221,0,0,12.0784194528875,51.8961230311296,STAT1;CCL2
Tumor Necrosis Factor-Mediated Signaling Pathway (GO:0033209),2/38,0.0143267007301561,0.113614068581005,0,0,11.74231678487,49.8535359200729,STAT1;BIRC3
Positive Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062208),2/39,0.0150544131229961,0.118012755745786,0,0,11.4243818286371,47.9376669435547,RSAD2;DDX60
Positive Regulation Of Viral Process (GO:0048524),2/41,0.0165565742985047,0.128313450813412,0,0,10.8374249863612,44.4439766103572,ADARB1;IFIT1
Defense Response To Bacterium (GO:0042742),4/204,0.0168536509632941,0.12914820176367,0,0,4.28347826086957,17.4902469099997,RNF213;OAS2;OAS3;GBP4
DNA Integrity Checkpoint Signaling (GO:0031570),2/42,0.0173306971443836,0.129885004972194,0,0,10.5659574468085,42.8478731064877,DTX3L;PARP9
Positive Regulation Of Calcium Ion Transmembrane Transport (GO:1904427),2/42,0.0173306971443836,0.129885004972194,0,0,10.5659574468085,42.8478731064877,CXCL10;CXCL9
Regulation Of Filopodium Assembly (GO:0051489),2/43,0.0181199661721693,0.134324097058907,0,0,10.3077322262584,41.3416426617247,FSCN1;AGRN
Cellular Response To Molecule Of Bacterial Origin (GO:0071219),3/117,0.0188047676629399,0.135855988999969,0,0,5.59988681380872,22.25196135462,CXCL10;CXCL9;CCL2
Lymphocyte Chemotaxis (GO:0048247),2/44,0.0189242213416379,0.135855988999969,0,0,10.0618034447822,39.9183198361125,CXCL10;CCL2
Positive Regulation Of Cytokine-Mediated Signaling Pathway (GO:0001961),2/44,0.0189242213416379,0.135855988999969,0,0,10.0618034447822,39.9183198361125,PARP14;PARP9
Regulation Of Protein Binding (GO:0043393),3/118,0.0192296080560263,0.136610340564687,0,0,5.55091164095372,21.933339933915,DTX3L;IFIT1;IFIT2
Cellular Response To Tumor Necrosis Factor (GO:0071356),3/119,0.0196597518135948,0.138226296256409,0,0,5.5027808676307,21.6214263699341,STAT1;CCL2;BIRC3
B Cell Receptor Signaling Pathway (GO:0050853),2/46,0.0205770557533159,0.140983588082977,0,0,9.60348162475822,37.2958759375975,BLNK;CD38
Protein Sumoylation (GO:0016925),2/46,0.0205770557533159,0.140983588082977,0,0,9.60348162475822,37.2958759375975,IFIH1;PML
Cellular Response To Lipopolysaccharide (GO:0071222),3/124,0.0218901111470154,0.140983588082977,0,0,5.27406025059984,20.1559830700601,CXCL10;CXCL9;CCL2
Post-Translational Protein Modification (GO:0043687),2/48,0.0222879431398908,0.140983588082977,0,0,9.1850138760407,34.9371237397634,PARP9;PARP12
Cellular Defense Response (GO:0006968),2/48,0.0222879431398908,0.140983588082977,0,0,9.1850138760407,34.9371237397634,LGALS3BP;CXCL9
Regulation Of Response To External Stimulus (GO:0032101),3/127,0.0232920932641708,0.140983588082977,0,0,5.14568158168574,19.3459170986296,HERC5;USP18;BIRC3
CD4-positive, Alpha-Beta T Cell Activation (GO:0035710),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,RSAD2
Establishment Of Protein Localization To Telomere (GO:0070200),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,BRCA2
Positive Regulation Of Interleukin-18 Production (GO:0032741),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,GBP5
PML Body Organization (GO:0030578),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,PML
Regulation Of Hematopoietic Stem Cell Proliferation (GO:1902033),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,EIF2AK2
Glyoxylate Metabolic Process (GO:0046487),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,HYI
Negative Regulation Of Protein Kinase Activity By Regulation Of Protein Phosphorylation (GO:0044387),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,ADARB1
Positive Regulation Of Podosome Assembly (GO:0071803),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,FSCN1
Positive Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034157),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,RSAD2
Attachment Of GPI Anchor To Protein (GO:0016255),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,PGAP1
Mesenchymal Cell Differentiation Involved In Kidney Development (GO:0072161),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,STAT1
Detection Of Virus (GO:0009597),1/5,0.0237728924186839,0.140983588082977,0,0,52.3684210526316,195.81648814875,RIGI
Positive Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050731),3/130,0.0247419087750398,0.145465360211872,0,0,5.02336804673609,18.582728212879,IL31RA;PARP9;PARP14
Regulation Of Release Of Sequestered Calcium Ion Into Cytosol (GO:0051279),2/51,0.0249604180826958,0.145495770362381,0,0,8.62136343899262,31.8168312776224,CXCL10;CXCL9
Regulation Of Protein Localization To Nucleus (GO:1900180),2/52,0.0258789386772382,0.148165476258353,0,0,8.44851063829787,30.8736105624491,DTX3L;PARP9
Positive Regulation Of Chemokine Production (GO:0032722),2/53,0.0268110563829108,0.148165476258353,0,0,8.28243637880684,29.9736479694775,OAS3;EIF2AK2
Protein K63-linked Ubiquitination (GO:0070534),2/54,0.0277566224412222,0.148165476258353,0,0,8.1227495908347,29.1142155700271,RNF213;TRIM22
Regulation Of Hemoglobin Biosynthetic Process (GO:0046984),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,EIF2AK2
Negative Regulation Of Response To Type II Interferon (GO:0060331),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,PARP14
Adenosine To Inosine Editing (GO:0006382),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,ADARB1
Positive Regulation Of Receptor Catabolic Process (GO:2000646),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,DTX3L
Negative Regulation Of Type II Interferon-Mediated Signaling Pathway (GO:0060336),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,PARP14
Interleukin-9-Mediated Signaling Pathway (GO:0038113),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,STAT1
Macrophage Derived Foam Cell Differentiation (GO:0010742),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,STAT1
Parallel Actin Filament Bundle Assembly (GO:0030046),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,FSCN1
Cellular Response To Interleukin-9 (GO:0071355),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,STAT1
Regulation Of Toll-Like Receptor 7 Signaling Pathway (GO:0034155),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,RSAD2
Regulation Of MDA-5 Signaling Pathway (GO:0039533),1/6,0.0284599375217657,0.148165476258353,0,0,41.8926315789474,149.106679129285,DDX60
Nucleotide-Excision Repair (GO:0006289),2/56,0.0296875099789714,0.152232194027507,0,0,7.82111899133176,27.5071012182479,FSCN1;BRCA2
Pattern Recognition Receptor Signaling Pathway (GO:0002221),2/56,0.0296875099789714,0.152232194027507,0,0,7.82111899133176,27.5071012182479,IFIH1;RIGI
Signal Transduction In Response To DNA Damage (GO:0042770),2/57,0.0306725393385369,0.155680973897591,0,0,7.67852998065764,26.7549739502837,DTX3L;PARP9
Positive Regulation Of DNA-binding Transcription Factor Activity (GO:0051091),4/246,0.0308166150677049,0.155680973897591,0,0,3.53251886453468,12.2921104293941,TRIM14;EIF2AK2;TRIM22;RIGI
Regulation Of Chemokine (C-C Motif) Ligand 5 Production (GO:0071649),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,OAS3
Foam Cell Differentiation (GO:0090077),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,STAT1
Folic Acid Transport (GO:0015884),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,FOLR3
Negative Regulation Of Osteoblast Proliferation (GO:0033689),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,EIF2AK2
Regulation Of Microvillus Organization (GO:0032530),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,FSCN1
Positive Regulation Of T-helper 2 Cell Cytokine Production (GO:2000553),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,RSAD2
Regulation Of Apoptotic Cell Clearance (GO:2000425),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,CCL2
Positive Regulation Of Extracellular Matrix Disassembly (GO:0090091),1/7,0.033124714124782,0.157979405825884,0,0,34.9087719298246,118.950789446359,FSCN1
Positive Regulation Of Phagocytosis (GO:0050766),2/60,0.0337042395194037,0.159627023279398,0,0,7.28026412325752,24.6810538084052,CCL2;C2
Negative Regulation Of Cell Population Proliferation (GO:0008285),5/379,0.0358906450634762,0.165778388235564,0,0,2.86918963389552,9.54659327002627,IFITM1;EIF2AK2;ADARB1;IFIT3;PML
Positive Regulation Of NF-kappaB Transcription Factor Activity (GO:0051092),3/152,0.0368280571283927,0.165778388235564,0,0,4.27689976185322,14.1201644723205,TRIM14;EIF2AK2;TRIM22
Regulation Of Epidermis Development (GO:0045682),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,KRT10
Positive Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071639),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,OAS3
Regulation Of Helicase Activity (GO:0051095),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,IFIT1
Regulation Of Interleukin-18 Production (GO:0032661),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,GBP5
Regulation Of Morphogenesis Of An Epithelium (GO:1905330),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,CXCL10
Regulation Of Pattern Recognition Receptor Signaling Pathway (GO:0062207),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,BIRC3
Regulation Of Podosome Assembly (GO:0071801),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,FSCN1
Protein poly-ADP-ribosylation (GO:0070212),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,PARP9
Positive Regulation Of Dendritic Cell Cytokine Production (GO:0002732),1/8,0.0377673265742596,0.165778388235564,0,0,29.9203007518797,98.0282082771779,RIGI
Cellular Response To Virus (GO:0098586),2/64,0.0379199832327683,0.165778388235564,0,0,6.80919698009609,22.2815789644713,IFIH1;CXCL10
Antimicrobial Humoral Immune Response Mediated By Antimicrobial Peptide (GO:0061844),2/65,0.0390039690340505,0.167773694159115,0,0,6.70077676460655,21.7379354108533,CXCL10;CXCL9
Response To Lipopolysaccharide (GO:0032496),3/159,0.0412039896683058,0.167773694159115,0,0,4.08354011579818,13.0233085868601,CXCL10;CXCL9;CCL2
Positive Regulation Of Mesenchymal Cell Proliferation (GO:0002053),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,STAT1
NAD Biosynthesis Via Nicotinamide Riboside Salvage Pathway (GO:0034356),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,PARP9
Negative Regulation Of Necroptotic Process (GO:0060546),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,BIRC3
Type II Interferon-Mediated Signaling Pathway (GO:0060333),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,STAT1
Negative Regulation Of Tyrosine Phosphorylation Of STAT Protein (GO:0042532),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,PARP14
Cell Differentiation Involved In Metanephros Development (GO:0072202),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,STAT1
Positive Regulation Of RIG-I Signaling Pathway (GO:1900246),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,DDX60
Regulation Of Viral-Induced Cytoplasmic Pattern Recognition Receptor Signaling Pathway (GO:0039531),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,BIRC3
Regulation Of ER To Golgi Vesicle-Mediated Transport (GO:0060628),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,PGAP1
Myeloid Dendritic Cell Differentiation (GO:0043011),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,BATF2
Response To Type I Interferon (GO:0034340),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,IFIT1
Positive Regulation Of Epidermis Development (GO:0045684),1/9,0.0423878788402831,0.167773694159115,0,0,26.1789473684211,82.7488471391098,KRT10
Regulation Of Endopeptidase Activity (GO:0052548),2/69,0.0434560271546039,0.167773694159115,0,0,6.29946014607812,19.7551430646846,SERPING1;BIRC3
Negative Regulation Of Epithelial Cell Proliferation (GO:0050680),2/70,0.0445974022062857,0.167773694159115,0,0,6.20650813516896,19.3027347613863,STAT1;BRCA2
Protein K48-linked Ubiquitination (GO:0070936),2/70,0.0445974022062857,0.167773694159115,0,0,6.20650813516896,19.3027347613863,DTX3L;IFI27
Negative Regulation Of Protein Binding (GO:0032091),2/71,0.0457498576645543,0.167773694159115,0,0,6.11625038544557,18.8659816465356,IFIT1;IFIT2
Myeloid Leukocyte Differentiation (GO:0002573),2/71,0.0457498576645543,0.167773694159115,0,0,6.11625038544557,18.8659816465356,BATF2;IL31RA
Positive Regulation Of Protein Localization To Nucleus (GO:1900182),2/72,0.0469132633268803,0.167773694159115,0,0,6.02857142857143,18.4441420557064,DTX3L;PARP9
CRD-mediated mRNA Stabilization (GO:0070934),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,IGF2BP3
Urogenital System Development (GO:0001655),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,EPHB3
T Cell Chemotaxis (GO:0010818),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,CXCL10
Negative Regulation Of Programmed Necrotic Cell Death (GO:0062099),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,BIRC3
Neuron Projection Fasciculation (GO:0106030),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,EPHB3
Regulation Of Programmed Necrotic Cell Death (GO:0062098),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,BIRC3
Protein auto-ADP-ribosylation (GO:0070213),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,PARP12
Mast Cell Activation Involved In Immune Response (GO:0002279),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,FCER1A
Mast Cell Degranulation (GO:0043303),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,FCER1A
Metanephric Mesenchyme Development (GO:0072075),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,STAT1
Regulation Of Toll-Like Receptor 9 Signaling Pathway (GO:0034163),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,RSAD2
Receptor-Mediated Endocytosis Of Virus By Host Cell (GO:0019065),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,SIGLEC1
Monocyte Differentiation (GO:0030224),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,IL31RA
Regulation Of T-helper 2 Cell Cytokine Production (GO:2000551),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,RSAD2
Endosomal Vesicle Fusion (GO:0034058),1/10,0.0469864744639165,0.167773694159115,0,0,23.2690058479532,71.15418818005,SAMD9
Protein Tetramerization (GO:0051262),2/73,0.0480874899858186,0.17081077172046,0,0,5.94336230146838,18.0365190097272,GBP5;KRT10
Histone H2A Ubiquitination (GO:0033522),1/11,0.0515632165556115,0.175331064713475,0,0,20.9410526315789,62.0891052745582,BRCA2
Regulation Of Mesenchymal Cell Proliferation (GO:0010464),1/11,0.0515632165556115,0.175331064713475,0,0,20.9410526315789,62.0891052745582,STAT1
Regulation Of Monocyte Chemotactic Protein-1 Production (GO:0071637),1/11,0.0515632165556115,0.175331064713475,0,0,20.9410526315789,62.0891052745582,OAS3
Macrophage Chemotaxis (GO:0048246),1/11,0.0515632165556115,0.175331064713475,0,0,20.9410526315789,62.0891052745582,CCL2
Mast Cell Mediated Immunity (GO:0002448),1/11,0.0515632165556115,0.175331064713475,0,0,20.9410526315789,62.0891052745582,FCER1A
Regulation Of Cell Cycle Checkpoint (GO:1901976),1/11,0.0515632165556115,0.175331064713475,0,0,20.9410526315789,62.0891052745582,BRCA2
DNA Repair (GO:0006281),4/291,0.0516114518847764,0.175331064713475,0,0,2.97182245114377,8.80851650174505,DTX3L;FSCN1;BRCA2;PARP9
Positive Regulation Of Nucleic Acid-Templated Transcription (GO:1903508),6/557,0.0516243009946048,0.175331064713475,0,0,2.34156079854809,6.93983071339089,DTX3L;STAT1;IL31RA;CD38;BRCA2;PARP9
Positive Regulation Of Interleukin-6 Production (GO:0032755),2/76,0.0516738181926809,0.175331064713475,0,0,5.70155261644623,16.892583147245,IFIH1;RIGI
Regulation Of Immune Response (GO:0050776),2/77,0.0528900558601742,0.177953680363132,0,0,5.62524822695035,16.5356418228624,RSAD2;BIRC3
Regulation Of Apoptotic Process (GO:0042981),7/705,0.0529686174687915,0.177953680363132,0,0,2.16416084478929,6.35842502791497,CXCL10;STAT1;IL31RA;CD38;IFIT3;IFIT2;BIRC3
Regulation Of Chemokine (C-X-C Motif) Ligand 2 Production (GO:2000341),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,OAS3
Positive Regulation Of Myeloid Leukocyte Mediated Immunity (GO:0002888),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,RIGI
Regulation Of Hematopoietic Stem Cell Differentiation (GO:1902036),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,EIF2AK2
Histone Monoubiquitination (GO:0010390),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,BRCA2
Axonal Fasciculation (GO:0007413),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,EPHB3
Nuclear Body Organization (GO:0030575),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,PML
Lipid Droplet Formation (GO:0140042),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,RNF213
Macrophage Migration (GO:1905517),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,CCL2
Protein Heterotetramerization (GO:0051290),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,KRT10
Mitochondrial Electron Transport, Ubiquinol To Cytochrome C (GO:0006122),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,UQCRFS1P1
Dendrite Self-Avoidance (GO:0070593),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,NEXN
Negative Regulation Of Complement Activation (GO:0045916),1/12,0.0561182077718237,0.178012175350622,0,0,19.0363636363636,54.8303422366207,SERPING1
Positive Regulation Of Immune Response (GO:0050778),2/80,0.05659941128668,0.178707400451462,0,0,5.40807419530824,15.5306732780957,GBP5;RSAD2
Positive Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032725),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,RIGI
Substrate-Dependent Cell Migration (GO:0006929),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,CD2AP
Suppression Of Viral Release By Host (GO:0044790),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,PML
Thymus Development (GO:0048538),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,EPHB3
Negative Regulation Of Translational Initiation (GO:0045947),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,EIF2AK2
Positive Regulation Of Type 2 Immune Response (GO:0002830),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,RSAD2
Myeloid Dendritic Cell Activation (GO:0001773),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,BATF2
Regulation Of T Cell Chemotaxis (GO:0010819),1/13,0.0606515503312197,0.184662309490589,0,0,17.4491228070175,48.9030875007602,CXCL10
Positive Regulation Of Protein Localization (GO:1903829),2/85,0.0629765113428553,0.190888803270343,0,0,5.08100487054601,14.0489452268152,DTX3L;PARP9
Negative Regulation Of Binding (GO:0051100),2/86,0.0642800829883675,0.1923870214084,0,0,5.02026342451874,13.7781403143116,IFIT1;IFIT2
Establishment Of Apical/Basal Cell Polarity (GO:0035089),1/14,0.0651633459609098,0.1923870214084,0,0,16.1060728744939,43.9834003197661,FSCN1
Establishment Of Protein Localization To Chromosome (GO:0070199),1/14,0.0651633459609098,0.1923870214084,0,0,16.1060728744939,43.9834003197661,BRCA2
Regulation Of Extracellular Matrix Disassembly (GO:0010715),1/14,0.0651633459609098,0.1923870214084,0,0,16.1060728744939,43.9834003197661,FSCN1
Histone H2A Monoubiquitination (GO:0035518),1/14,0.0651633459609098,0.1923870214084,0,0,16.1060728744939,43.9834003197661,BRCA2
Regulation Of Non-Canonical Wnt Signaling Pathway (GO:2000050),1/14,0.0651633459609098,0.1923870214084,0,0,16.1060728744939,43.9834003197661,RNF213
Positive Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120034),2/88,0.0669144425135934,0.196296779534847,0,0,4.90301830776843,13.2594307516481,FSCN1;AGRN
Regulation Of Programmed Cell Death (GO:0043067),3/195,0.0675731131073221,0.196296779534847,0,0,3.31182795698925,8.92386982716208,CXCL10;STAT1;BIRC3
Positive Regulation Of Cytokine Production (GO:0001819),4/320,0.0682434607229701,0.196296779534847,0,0,2.69510181618052,7.23546886524677,IFIH1;GBP5;EIF2AK2;RIGI
Negative Regulation Of Macrophage Activation (GO:0043031),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,IL31RA
Regulation Of Granulocyte Macrophage Colony-Stimulating Factor Production (GO:0032645),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,RIGI
Alpha-Beta T Cell Activation (GO:0046631),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,RSAD2
Cardiac Myofibril Assembly (GO:0055003),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,NEBL
Protein Localization To Chromosome, Telomeric Region (GO:0070198),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,BRCA2
Dendritic Spine Morphogenesis (GO:0060997),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,EPHB3
Digestive Tract Morphogenesis (GO:0048546),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,EPHB3
Positive Regulation Of Endothelial Cell Apoptotic Process (GO:2000353),1/15,0.069653695963978,0.196296779534847,0,0,14.9548872180451,39.8431023762453,CCL2
Regulation Of RNA Metabolic Process (GO:0051252),2/91,0.0709323050351309,0.196541691746348,0,0,4.73703083911069,12.5343224283219,OAS2;OAS3
Positive Regulation Of Binding (GO:0051099),2/91,0.0709323050351309,0.196541691746348,0,0,4.73703083911069,12.5343224283219,DTX3L;PARP9
Regulation Of Translation (GO:0006417),3/202,0.0734146350438302,0.196541691746348,0,0,3.19419679040363,8.34206647455582,SAMD4A;EIF2AK2;IGF2BP3
Negative Regulation Of Amide Metabolic Process (GO:0034249),2/93,0.0736537800118073,0.196541691746348,0,0,4.63245265372925,12.0831959885246,EIF2AK2;IGF2BP3
Stabilization Of Membrane Potential (GO:0030322),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,KCNK13
DNA Repair-Dependent Chromatin Remodeling (GO:0140861),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,DTX3L
Positive Regulation Of Lymphocyte Migration (GO:2000403),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,CXCL10
Positive Regulation Of Myeloid Leukocyte Cytokine Production Involved In Immune Response (GO:0061081),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,RIGI
Negative Regulation Of Receptor Signaling Pathway Via JAK-STAT (GO:0046426),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,PARP14
Regulation Of Osteoblast Proliferation (GO:0033688),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,EIF2AK2
Regulation Of Secretion (GO:0051046),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,OAS2
Regulation Of Stem Cell Proliferation (GO:0072091),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,EIF2AK2
Regulation Of NMDA Receptor Activity (GO:2000310),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,CCL2
Negative Regulation Of ATP-dependent Activity (GO:0032780),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,IFIT1
Negative Regulation Of Chemokine Production (GO:0032682),1/16,0.0741227011346479,0.196541691746348,0,0,13.9571929824561,36.3170828061569,OAS3
Positive Regulation Of DNA-templated Transcription (GO:0045893),10/1243,0.0745661402494602,0.196541691746348,0,0,1.76078386993342,4.57111599584662,CXCL10;DTX3L;STAT1;IL31RA;CD38;NCOA7;BRCA2;PARP9;AGRN;RIGI
Peptidyl-Lysine Modification (GO:0018205),2/94,0.0750270543685967,0.196541691746348,0,0,4.58186864014801,11.8666113988176,IFIH1;PML
Regulation Of Angiogenesis (GO:0045765),3/205,0.0759853704503069,0.196541691746348,0,0,3.14627914404344,8.10863607785278,CXCL10;STAT1;PML
Recombinational Repair (GO:0000725),2/95,0.0764085405450076,0.196541691746348,0,0,4.53237245481583,11.6557245812943,FSCN1;BRCA2
Negative Regulation Of Gene Expression (GO:0010629),4/336,0.0784756128854715,0.196541691746348,0,0,2.56312205343112,6.52306198192635,EIF2AK2;IGF2BP3;PARP9;PARP14
DNA Damage Response, Signal Transduction By P53 Class Mediator Resulting In Cell Cycle Arrest (GO:0006977),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,PML
Negative Regulation Of Leukocyte Activation (GO:0002695),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,IL31RA
NAD Biosynthetic Process (GO:0009435),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,PARP9
Regulation Of Hematopoietic Progenitor Cell Differentiation (GO:1901532),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,EIF2AK2
T Cell Migration (GO:0072678),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,CXCL10
Negative Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051444),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,DTX3L
Base Conversion Or Substitution Editing (GO:0016553),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,ADARB1
Peptidyl-Threonine Dephosphorylation (GO:0035970),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,PPM1K
Negative Regulation Of Rho Protein Signal Transduction (GO:0035024),1/17,0.0785704618658467,0.196541691746348,0,0,13.0842105263158,33.2830842167513,HEG1
Negative Regulation Of Macromolecule Biosynthetic Process (GO:0010558),2/98,0.0806011891219634,0.196541691746348,0,0,4.39007092198582,11.0552604352508,EIF2AK2;IGF2BP3
MAPK Cascade (GO:0000165),2/98,0.0806011891219634,0.196541691746348,0,0,4.39007092198582,11.0552604352508,IL31RA;CCL2
Positive Regulation Of Protein-Containing Complex Assembly (GO:0031334),2/98,0.0806011891219634,0.196541691746348,0,0,4.39007092198582,11.0552604352508,GBP5;FSCN1
Negative Regulation Of Apoptotic Process (GO:0043066),5/482,0.0824288162881586,0.196541691746348,0,0,2.23777270947082,5.58507831109187,IL31RA;CD38;CCL2;IFIT3;BIRC3
Regulation Of Defense Response To Virus (GO:0050688),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,HERC5
Positive Regulation Of Monocyte Chemotaxis (GO:0090026),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,CXCL10
Positive Regulation Of Neuroblast Proliferation (GO:0002052),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,HAPLN3
Vesicle-Mediated Transport In Synapse (GO:0099003),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,OTOF
Positive Regulation Of Stress-Activated Protein Kinase Signaling Cascade (GO:0070304),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,EIF2AK2
Maintenance Of Protein Localization In Organelle (GO:0072595),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,PML
Maintenance Of Protein Location In Nucleus (GO:0051457),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,PML
Regulation Of Vascular Endothelial Cell Proliferation (GO:1905562),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,CCL2
Positive Regulation Of NLRP3 Inflammasome Complex Assembly (GO:1900227),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,GBP5
Regulation Of DNA Damage Checkpoint (GO:2000001),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,BRCA2
Response To Organophosphorus (GO:0046683),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,STAT1
Positive Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900017),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,GBP5
Positive Regulation Of Extracellular Matrix Organization (GO:1903055),1/18,0.0829970780395137,0.196541691746348,0,0,12.3139318885449,30.6487592488941,FSCN1
Antimicrobial Humoral Response (GO:0019730),2/100,0.0834353800745876,0.196895948826535,0,0,4.30004342162397,10.6799440491835,CXCL10;CXCL9
Regulation Of GTPase Activity (GO:0043087),3/214,0.0839330363581409,0.197387347573283,0,0,3.01070172756459,7.45972400830068,CCL2;AGRN;EPHB3
Regulation Of Protein Secretion (GO:0050708),2/102,0.0862998644640731,0.202256039740542,0,0,4.2136170212766,10.3230551674499,RSAD2;CD2AP
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage By P53 Class Mediator (GO:0042771),1/19,0.0874026490788467,0.203442343589671,0,0,11.6292397660819,28.3431283945933,PML
Protein Heterooligomerization (GO:0051291),1/19,0.0874026490788467,0.203442343589671,0,0,11.6292397660819,28.3431283945933,KRT10
Negative Regulation Of Small GTPase Mediated Signal Transduction (GO:0051058),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,CD2AP
Regulation Of Necroptotic Process (GO:0060544),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,BIRC3
Nuclear-Transcribed mRNA poly(A) Tail Shortening (GO:0000289),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,SAMD4A
Lipopolysaccharide-Mediated Signaling Pathway (GO:0031663),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,CCL2
Regulation Of Toll-Like Receptor Signaling Pathway (GO:0034121),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,BIRC3
Regulation Of Calcium Ion Import (GO:0090279),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,CCL2
Sensory Perception Of Pain (GO:0019233),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,CCL2
Endoplasmic Reticulum Calcium Ion Homeostasis (GO:0032469),1/20,0.0917872740073592,0.207969836787438,0,0,11.016620498615,26.3107922330276,PML
Negative Regulation Of Translation (GO:0017148),2/107,0.0935882228241603,0.211348238298269,0,0,4.01195542046606,9.50372351824734,EIF2AK2;IGF2BP3
Regulation Of Neurotransmitter Transport (GO:0051588),1/21,0.0961510513071088,0.213599403880939,0,0,10.4652631578947,24.5079182180271,OTOF
Macrophage Differentiation (GO:0030225),1/21,0.0961510513071088,0.213599403880939,0,0,10.4652631578947,24.5079182180271,IL31RA
Modulation By Host Of Viral Genome Replication (GO:0044827),1/21,0.0961510513071088,0.213599403880939,0,0,10.4652631578947,24.5079182180271,IFI27
Modulation By Symbiont Of Entry Into Host (GO:0052372),1/21,0.0961510513071088,0.213599403880939,0,0,10.4652631578947,24.5079182180271,TRIM22
Positive Regulation Of T Cell Cytokine Production (GO:0002726),1/21,0.0961510513071088,0.213599403880939,0,0,10.4652631578947,24.5079182180271,RSAD2
Cellular Response To Lipid (GO:0071396),3/228,0.0969701129571718,0.214719535833738,0,0,2.82136200716846,6.58323198505316,CXCL10;CXCL9;CCL2
Adenylate Cyclase-Activating G Protein-Coupled Receptor Signaling Pathway (GO:0007189),2/110,0.0980444154024719,0.216395764739436,0,0,3.89992119779354,9.05692226480929,CXCL10;CXCL9
Double-Strand Break Repair Via Homologous Recombination (GO:0000724),2/111,0.0995430872693535,0.217577656913468,0,0,3.8639469061097,8.91476186839404,FSCN1;BRCA2
Positive Regulation Of Synaptic Transmission, Glutamatergic (GO:0051968),1/22,0.100494079072936,0.217577656913468,0,0,9.96641604010025,22.8994002764751,CCL2
Regulation Of Protein Export From Nucleus (GO:0046825),1/22,0.100494079072936,0.217577656913468,0,0,9.96641604010025,22.8994002764751,IFI27
Cellular Response To Interferon-Beta (GO:0035458),1/22,0.100494079072936,0.217577656913468,0,0,9.96641604010025,22.8994002764751,STAT1
Modulation By Host Of Viral Process (GO:0044788),1/22,0.100494079072936,0.217577656913468,0,0,9.96641604010025,22.8994002764751,IFI27
Dendritic Cell Differentiation (GO:0097028),1/22,0.100494079072936,0.217577656913468,0,0,9.96641604010025,22.8994002764751,BATF2
Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043122),3/232,0.100838991843508,0.217633520371115,0,0,2.77151711508663,6.35849819401399,STAT1;TRIM22;BIRC3
Regulation Of Cytoskeleton Organization (GO:0051493),2/114,0.10407758453335,0.221315239144367,0,0,3.75987841945289,8.50717104424932,FSCN1;NEXN
Regulation Of Interleukin-6 Production (GO:0032675),2/114,0.10407758453335,0.221315239144367,0,0,3.75987841945289,8.50717104424932,IFIH1;RIGI
Positive Regulation Of Lamellipodium Assembly (GO:0010592),1/23,0.104816454902684,0.221315239144367,0,0,9.51291866028708,21.4568114296548,FSCN1
Protein Localization To Cell Junction (GO:1902414),1/23,0.104816454902684,0.221315239144367,0,0,9.51291866028708,21.4568114296548,HEG1
Regulation Of T Cell Migration (GO:2000404),1/23,0.104816454902684,0.221315239144367,0,0,9.51291866028708,21.4568114296548,CXCL10
Positive Regulation Of Epithelial Cell Apoptotic Process (GO:1904037),1/23,0.104816454902684,0.221315239144367,0,0,9.51291866028708,21.4568114296548,CCL2
Entrainment Of Circadian Clock By Photoperiod (GO:0043153),1/23,0.104816454902684,0.221315239144367,0,0,9.51291866028708,21.4568114296548,PML
Regulation Of Cysteine-Type Endopeptidase Activity (GO:2000116),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,BIRC3
Gliogenesis (GO:0042063),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,HAPLN3
Regulation Of Neuroblast Proliferation (GO:1902692),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,HAPLN3
Protein Kinase B Signaling (GO:0043491),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,CCL2
Photoperiodism (GO:0009648),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,PML
Mononuclear Cell Differentiation (GO:1903131),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,IL31RA
Regulation Of Viral Life Cycle (GO:1903900),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,TRIM22
Response To Purine-Containing Compound (GO:0014074),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,STAT1
Dicarboxylic Acid Transport (GO:0006835),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,FOLR3
Eosinophil Chemotaxis (GO:0048245),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,CCL2
Eosinophil Migration (GO:0072677),1/24,0.109118275963612,0.222810371877796,0,0,9.09885583524027,20.1569035542602,CCL2
Negative Regulation Of Programmed Cell Death (GO:0043069),4/381,0.111055173115058,0.226088441983492,0,0,2.25198938992042,4.94926046687946,IL31RA;CD38;IFIT3;BIRC3
Negative Regulation Of Protein Transport (GO:0051224),1/25,0.113399638968481,0.227466334636776,0,0,8.71929824561403,18.9804916575847,RSAD2
Negative Regulation Of Proteolysis Involved In Protein Catabolic Process (GO:1903051),1/25,0.113399638968481,0.227466334636776,0,0,8.71929824561403,18.9804916575847,PML
Regulation Of Monocyte Chemotaxis (GO:0090025),1/25,0.113399638968481,0.227466334636776,0,0,8.71929824561403,18.9804916575847,CXCL10
Positive Regulation Of T Cell Migration (GO:2000406),1/25,0.113399638968481,0.227466334636776,0,0,8.71929824561403,18.9804916575847,CXCL10
Response To dsRNA (GO:0043331),1/25,0.113399638968481,0.227466334636776,0,0,8.71929824561403,18.9804916575847,RIGI
Negative Regulation Of Cellular Process (GO:0048523),5/537,0.116217148252887,0.231920683791116,0,0,2.00074361728497,4.30619022392066,IFITM1;EIF2AK2;ADARB1;IFIT3;PML
Positive Regulation Of Macromolecule Biosynthetic Process (GO:0010557),2/122,0.116435402727176,0.231920683791116,0,0,3.50780141843972,7.54324156540912,SAMD4A;CCL2
Establishment Or Maintenance Of Apical/Basal Cell Polarity (GO:0035088),1/26,0.117660640163821,0.231920683791116,0,0,8.37010526315789,17.9116128577482,FSCN1
Mitotic G1 DNA Damage Checkpoint Signaling (GO:0031571),1/26,0.117660640163821,0.231920683791116,0,0,8.37010526315789,17.9116128577482,PML
Dendritic Spine Organization (GO:0097061),1/26,0.117660640163821,0.231920683791116,0,0,8.37010526315789,17.9116128577482,EPHB3
Positive Regulation Of Erythrocyte Differentiation (GO:0045648),1/26,0.117660640163821,0.231920683791116,0,0,8.37010526315789,17.9116128577482,STAT1
Regulation Of Cell Motility (GO:2000145),2/123,0.118005684677272,0.231930481123629,0,0,3.47863548443819,7.4339222315207,NEXN;RIGI
Neuron Projection Guidance (GO:0097485),2/124,0.119581350952225,0.233680462319249,0,0,3.44994768050227,7.32685529053137,NEXN;EPHB3
Enzyme-Linked Receptor Protein Signaling Pathway (GO:0007167),2/124,0.119581350952225,0.233680462319249,0,0,3.44994768050227,7.32685529053137,BLNK;IL31RA
Positive Regulation Of Immune System Process (GO:0002684),1/27,0.121901375379384,0.23484954239757,0,0,8.04777327935223,16.9368845963935,RSAD2
GPI Anchor Metabolic Process (GO:0006505),1/27,0.121901375379384,0.23484954239757,0,0,8.04777327935223,16.9368845963935,PGAP1
Peptide Cross-Linking (GO:0018149),1/27,0.121901375379384,0.23484954239757,0,0,8.04777327935223,16.9368845963935,KRT10
Clathrin-Dependent Endocytosis (GO:0072583),1/27,0.121901375379384,0.23484954239757,0,0,8.04777327935223,16.9368845963935,SIGLEC1
Positive Regulation Of Filopodium Assembly (GO:0051491),1/27,0.121901375379384,0.23484954239757,0,0,8.04777327935223,16.9368845963935,FSCN1
Protein-Containing Complex Organization (GO:0043933),2/126,0.122748491475666,0.235815411792689,0,0,3.3939601921757,7.11923131766406,PML;CD2AP
Protein Localization To Golgi Apparatus (GO:0034067),1/28,0.126121939976367,0.240265818614197,0,0,7.74931773879142,16.0450093579047,GBP5
Membrane Fusion (GO:0061025),1/28,0.126121939976367,0.240265818614197,0,0,7.74931773879142,16.0450093579047,OTOF
Pyroptosis (GO:0070269),1/28,0.126121939976367,0.240265818614197,0,0,7.74931773879142,16.0450093579047,IFI27
Cellular Component Assembly (GO:0022607),3/260,0.129564360966674,0.243506565790766,0,0,2.46604744571357,5.03955913668567,FSCN1;PML;CD2AP
Regulation Of DNA-templated Transcription (GO:0006355),13/1922,0.129613841195718,0.243506565790766,0,0,1.47642429329681,3.01662376953158,BATF2;DTX3L;STAT1;SP140;IL31RA;BRCA2;PARP9;PML;ETV7;ZNF219;CD38;NCOA7;TRIM22
Positive Regulation Of Neural Precursor Cell Proliferation (GO:2000179),1/29,0.130322428905615,0.243506565790766,0,0,7.47218045112782,15.2263884665744,HAPLN3
Lipid Droplet Organization (GO:0034389),1/29,0.130322428905615,0.243506565790766,0,0,7.47218045112782,15.2263884665744,RNF213
Positive Regulation Of B Cell Proliferation (GO:0030890),1/29,0.130322428905615,0.243506565790766,0,0,7.47218045112782,15.2263884665744,CD38
Modified Amino Acid Transport (GO:0072337),1/29,0.130322428905615,0.243506565790766,0,0,7.47218045112782,15.2263884665744,FOLR3
Positive Regulation Of Calcium Ion Transport (GO:0051928),1/29,0.130322428905615,0.243506565790766,0,0,7.47218045112782,15.2263884665744,CCL2
Negative Regulation Of Cell Motility (GO:2000146),2/133,0.133990607790531,0.248593503416664,0,0,3.21146662335553,6.45500157984121,IFITM1;ADARB1
GPI Anchor Biosynthetic Process (GO:0006506),1/30,0.134502936599339,0.248593503416664,0,0,7.21415607985481,14.472818068488,PGAP1
Negative Regulation Of Peptidyl-Tyrosine Phosphorylation (GO:0050732),1/30,0.134502936599339,0.248593503416664,0,0,7.21415607985481,14.472818068488,PARP14
Immunoglobulin Mediated Immune Response (GO:0016064),1/30,0.134502936599339,0.248593503416664,0,0,7.21415607985481,14.472818068488,FCER1A
Antigen Receptor-Mediated Signaling Pathway (GO:0050851),2/134,0.135615476387712,0.249972310530864,0,0,3.18697614442295,6.36736091255354,BLNK;CD38
Positive Regulation Of Lamellipodium Organization (GO:1902745),1/31,0.13866355715087,0.252857074804527,0,0,6.97333333333333,13.7772476647114,FSCN1
Positive Regulation Of Mononuclear Cell Migration (GO:0071677),1/31,0.13866355715087,0.252857074804527,0,0,6.97333333333333,13.7772476647114,CXCL10
Regulation Of Macrophage Activation (GO:0043030),1/31,0.13866355715087,0.252857074804527,0,0,6.97333333333333,13.7772476647114,IL31RA
Positive Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001238),1/31,0.13866355715087,0.252857074804527,0,0,6.97333333333333,13.7772476647114,PML
Negative Regulation Of Cellular Biosynthetic Process (GO:0031327),2/137,0.140516591753188,0.255552841535131,0,0,3.11568163908589,6.11430620425986,EIF2AK2;IGF2BP3
NIK/NF-kappaB Signaling (GO:0038061),1/32,0.142804384168132,0.256296289480701,0,0,6.74804753820034,13.1335867781803,BIRC3
Amide Transport (GO:0042886),1/32,0.142804384168132,0.256296289480701,0,0,6.74804753820034,13.1335867781803,FOLR3
Positive Regulation Of Synapse Assembly (GO:0051965),1/32,0.142804384168132,0.256296289480701,0,0,6.74804753820034,13.1335867781803,EPHB3
Regulation Of Ubiquitin-Protein Transferase Activity (GO:0051438),1/32,0.142804384168132,0.256296289480701,0,0,6.74804753820034,13.1335867781803,DTX3L
Negative Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000134),1/32,0.142804384168132,0.256296289480701,0,0,6.74804753820034,13.1335867781803,CCL2
Positive Regulation Of Ion Transmembrane Transporter Activity (GO:0032414),1/33,0.1469255107829,0.25959377811901,0,0,6.53684210526316,12.5365489531719,CCL2
Glycolipid Metabolic Process (GO:0006664),1/33,0.1469255107829,0.25959377811901,0,0,6.53684210526316,12.5365489531719,PGAP1
Actin Filament Bundle Assembly (GO:0051017),1/33,0.1469255107829,0.25959377811901,0,0,6.53684210526316,12.5365489531719,FSCN1
Actin Filament Bundle Organization (GO:0061572),1/33,0.1469255107829,0.25959377811901,0,0,6.53684210526316,12.5365489531719,FSCN1
Regulation Of Lamellipodium Assembly (GO:0010591),1/33,0.1469255107829,0.25959377811901,0,0,6.53684210526316,12.5365489531719,FSCN1
Positive Regulation Of Chromosome Organization (GO:2001252),1/33,0.1469255107829,0.25959377811901,0,0,6.53684210526316,12.5365489531719,PML
Glial Cell Differentiation (GO:0010001),1/34,0.151027029770598,0.264103677701405,0,0,6.3384370015949,11.9815249822075,HAPLN3
Apoptotic Mitochondrial Changes (GO:0008637),1/34,0.151027029770598,0.264103677701405,0,0,6.3384370015949,11.9815249822075,IFIT2
Purine Nucleotide Metabolic Process (GO:0006163),1/34,0.151027029770598,0.264103677701405,0,0,6.3384370015949,11.9815249822075,CD38
Negative Regulation Of Ras Protein Signal Transduction (GO:0046580),1/34,0.151027029770598,0.264103677701405,0,0,6.3384370015949,11.9815249822075,HEG1
Actin Filament Organization (GO:0007015),2/144,0.152097221951145,0.265294898646243,0,0,2.96104285286185,5.57634055710246,NEBL;CD2AP
Intrinsic Apoptotic Signaling Pathway By P53 Class Mediator (GO:0072332),1/35,0.15510903343194,0.268037137023848,0,0,6.15170278637771,11.4644792109869,PML
Dendrite Morphogenesis (GO:0048813),1/35,0.15510903343194,0.268037137023848,0,0,6.15170278637771,11.4644792109869,EPHB3
Negative Regulation Of Cell Cycle G1/S Phase Transition (GO:1902807),1/35,0.15510903343194,0.268037137023848,0,0,6.15170278637771,11.4644792109869,CCL2
Positive Regulation Of Cellular Catabolic Process (GO:0031331),2/146,0.155440464056519,0.268037137023848,0,0,2.91962174940898,5.43485395572526,DTX3L;TRIM22
Regulation Of Cell Migration (GO:0030334),4/434,0.155861870282028,0.268037137023848,0,0,1.9690596562184,3.66005877141788,IFITM1;NEXN;ADARB1;RIGI
Transmembrane Receptor Protein Tyrosine Kinase Signaling Pathway (GO:0007169),3/284,0.156214514306585,0.268037137023848,0,0,2.25266903914591,4.18213666857506,BLNK;IL31RA;EPHB3
Negative Regulation Of Protein Metabolic Process (GO:0051248),2/147,0.15711746624804,0.268037137023848,0,0,2.8993396918562,5.3659864531797,EIF2AK2;IGF2BP3
Substrate Adhesion-Dependent Cell Spreading (GO:0034446),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,EPHB3
DNA Damage Response, Signal Transduction By P53 Class Mediator (GO:0030330),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,PML
Regulation Of Erythrocyte Differentiation (GO:0045646),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,STAT1
Positive Regulation Of Myeloid Cell Differentiation (GO:0045639),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,STAT1
Regulation Of Intracellular Protein Transport (GO:0033157),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,IFI27
Positive Regulation Of Signaling Receptor Activity (GO:2000273),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,CCL2
Interstrand Cross-Link Repair (GO:0036297),1/36,0.159171613628531,0.268037137023848,0,0,5.97563909774436,10.9818641748964,FSCN1
Axon Guidance (GO:0007411),2/149,0.160481874556633,0.269577927210895,0,0,2.85960341583442,5.23185684316889,NEXN;EPHB3
Positive Regulation Of Immune Effector Process (GO:0002699),1/37,0.163214861842966,0.272157789185581,0,0,5.8093567251462,10.5305499185177,DDX60
Synaptic Vesicle Cycle (GO:0099504),1/37,0.163214861842966,0.272157789185581,0,0,5.8093567251462,10.5305499185177,OTOF
Negative Regulation Of Transferase Activity (GO:0051348),1/37,0.163214861842966,0.272157789185581,0,0,5.8093567251462,10.5305499185177,DTX3L
Regulation Of Intracellular Transport (GO:0032386),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,MX2
Negative Regulation Of Type I Interferon Production (GO:0032480),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,XAF1
Regulation Of Neurotransmitter Secretion (GO:0046928),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,OTOF
Maturation Of SSU-rRNA (GO:0030490),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,IGF2BP3
Regulation Of Telomere Maintenance (GO:0032204),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,PML
Response To cAMP (GO:0051591),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,STAT1
Response To Peptide (GO:1901652),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,STAT1
Signal Release From Synapse (GO:0099643),1/38,0.167238869060356,0.273517766664659,0,0,5.65206258890469,10.1077651561587,OTOF
Epithelium Development (GO:0060429),2/154,0.168950309758435,0.275443917624061,0,0,2.76483762597984,4.91629777309432,STAT1;KRT10
Positive Regulation Of Intracellular Transport (GO:0032388),1/39,0.171243725912906,0.275443917624061,0,0,5.50304709141274,9.71104802033864,PGAP1
Negative Regulation Of Protein Secretion (GO:0050709),1/39,0.171243725912906,0.275443917624061,0,0,5.50304709141274,9.71104802033864,RSAD2
Vitamin Transport (GO:0051180),1/39,0.171243725912906,0.275443917624061,0,0,5.50304709141274,9.71104802033864,FOLR3
Negative Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000059),1/39,0.171243725912906,0.275443917624061,0,0,5.50304709141274,9.71104802033864,PML
Nuclear-Transcribed mRNA Catabolic Process, Deadenylation-Dependent Decay (GO:0000288),1/39,0.171243725912906,0.275443917624061,0,0,5.50304709141274,9.71104802033864,SAMD4A
Digestive Tract Development (GO:0048565),1/39,0.171243725912906,0.275443917624061,0,0,5.50304709141274,9.71104802033864,EPHB3
Regulation Of Nucleic Acid-Templated Transcription (GO:1903506),4/452,0.172435855546778,0.276150448002842,0,0,1.88819875776398,3.31894353369271,ZNF219;BRCA2;TRIM22;PML
Regulation Of Cell Cycle (GO:0051726),3/298,0.172492801831687,0.276150448002842,0,0,2.14423182066703,3.76827251252668,MX2;ADARB1;BIRC3
Regulation Of Gene Expression (GO:0010468),8/1127,0.17337014988279,0.276905016908812,0,0,1.52611909984564,2.67425875075156,ZNF219;IGF2BP3;BRCA2;PARP9;PARP14;TRIM22;PML;RIGI
Negative Regulation Of Mitotic Cell Cycle Phase Transition (GO:1901991),1/40,0.175229522570842,0.277922173007707,0,0,5.36167341430499,9.33820464914985,CCL2
Negative Regulation Of Secretion By Cell (GO:1903531),1/40,0.175229522570842,0.277922173007707,0,0,5.36167341430499,9.33820464914985,RSAD2
Endothelial Cell Migration (GO:0043542),1/40,0.175229522570842,0.277922173007707,0,0,5.36167341430499,9.33820464914985,STAT1
Regulation Of Chemokine Production (GO:0032642),1/41,0.17919634880774,0.28094691928018,0,0,5.22736842105263,8.98727419032195,EIF2AK2
Synaptic Vesicle Exocytosis (GO:0016079),1/41,0.17919634880774,0.28094691928018,0,0,5.22736842105263,8.98727419032195,OTOF
Positive Regulation Of Response To Biotic Stimulus (GO:0002833),1/41,0.17919634880774,0.28094691928018,0,0,5.22736842105263,8.98727419032195,GBP5
Lymphocyte Migration (GO:0072676),1/41,0.17919634880774,0.28094691928018,0,0,5.22736842105263,8.98727419032195,CCL2
Response To Amino Acid Starvation (GO:1990928),1/41,0.17919634880774,0.28094691928018,0,0,5.22736842105263,8.98727419032195,EIF2AK2
Protein Autophosphorylation (GO:0046777),2/162,0.182652758026863,0.281951260625958,0,0,2.62553191489362,4.46384646260582,EIF2AK2;EPHB3
Keratinocyte Differentiation (GO:0030216),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,KRT10
Lysosome Localization (GO:0032418),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,FCER1A
Cellular Response To Amino Acid Starvation (GO:0034198),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,EIF2AK2
Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000058),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,PML
Monocyte Chemotaxis (GO:0002548),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,CCL2
Negative Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043124),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,STAT1
Regulation Of Axonogenesis (GO:0050770),1/42,0.183144293925659,0.281951260625958,0,0,5.09961489088575,8.65649910635914,EPHB3
Adenylate Cyclase-Modulating G Protein-Coupled Receptor Signaling Pathway (GO:0007188),2/163,0.184377421809201,0.282573936345787,0,0,2.60909211047971,4.41137575494355,CXCL10;CXCL9
Negative Regulation Of Cell Migration (GO:0030336),2/163,0.184377421809201,0.282573936345787,0,0,2.60909211047971,4.41137575494355,IFITM1;ADARB1
Regulation Of Endothelial Cell Apoptotic Process (GO:2000351),1/43,0.187073446888762,0.283520201729191,0,0,4.97794486215539,8.34429986315675,CCL2
Neurotransmitter Secretion (GO:0007269),1/43,0.187073446888762,0.283520201729191,0,0,4.97794486215539,8.34429986315675,OTOF
Regulation Of Primary Metabolic Process (GO:0080090),1/43,0.187073446888762,0.283520201729191,0,0,4.97794486215539,8.34429986315675,RNF213
Regulation Of Cell-Cell Adhesion (GO:0022407),1/43,0.187073446888762,0.283520201729191,0,0,4.97794486215539,8.34429986315675,EPHB3
Ephrin Receptor Signaling Pathway (GO:0048013),1/43,0.187073446888762,0.283520201729191,0,0,4.97794486215539,8.34429986315675,EPHB3
Positive Regulation Of Leukocyte Cell-Cell Adhesion (GO:1903039),1/44,0.190983896201748,0.287529839314772,0,0,4.86193390452876,8.0492532812989,CCL2
Positive Regulation Of Osteoblast Differentiation (GO:0045669),1/44,0.190983896201748,0.287529839314772,0,0,4.86193390452876,8.0492532812989,IFITM1
Regulation Of B Cell Proliferation (GO:0030888),1/44,0.190983896201748,0.287529839314772,0,0,4.86193390452876,8.0492532812989,CD38
Positive Regulation Of Innate Immune Response (GO:0045089),1/45,0.194875729950532,0.291458876811979,0,0,4.7511961722488,7.77007393987043,GBP5
I-kappaB kinase/NF-kappaB Signaling (GO:0007249),1/45,0.194875729950532,0.291458876811979,0,0,4.7511961722488,7.77007393987043,BIRC3
Regulation Of Stem Cell Differentiation (GO:2000736),1/45,0.194875729950532,0.291458876811979,0,0,4.7511961722488,7.77007393987043,EIF2AK2
Epithelial Cell Migration (GO:0010631),1/46,0.198749035823811,0.295309024905968,0,0,4.64538011695906,7.50559814926295,STAT1
Regulation Of Cytokine Production Involved In Inflammatory Response (GO:1900015),1/46,0.198749035823811,0.295309024905968,0,0,4.64538011695906,7.50559814926295,GBP5
Replication Fork Processing (GO:0031297),1/46,0.198749035823811,0.295309024905968,0,0,4.64538011695906,7.50559814926295,BRCA2
Positive Regulation Of Lymphocyte Activation (GO:0051251),1/47,0.20260390111696,0.299730717053724,0,0,4.5441647597254,7.25477009070381,CCL2
Positive Regulation Of Smooth Muscle Cell Proliferation (GO:0048661),1/47,0.20260390111696,0.299730717053724,0,0,4.5441647597254,7.25477009070381,STAT1
Positive Regulation Of I-kappaB kinase/NF-kappaB Signaling (GO:0043123),2/175,0.205245000870573,0.302980715570846,0,0,2.42663878981675,3.84270600862683,TRIM22;BIRC3
Cellular Response To Radiation (GO:0071478),1/48,0.206440412672817,0.304087173742681,0,0,4.44725643896976,7.01662979135611,BRCA2
Positive Regulation Of Hydrolase Activity (GO:0051345),2/176,0.206996469467681,0.304249121071031,0,0,2.41257031058939,3.79992741198987,CCL2;AGRN
Positive Regulation Of Nervous System Development (GO:0051962),1/49,0.21025865699509,0.307717605301827,0,0,4.35438596491228,6.79030265440122,EPHB3
Intrinsic Apoptotic Signaling Pathway In Response To DNA Damage (GO:0008630),1/49,0.21025865699509,0.307717605301827,0,0,4.35438596491228,6.79030265440122,PML
G Protein-Coupled Receptor Signaling Pathway, Coupled To Cyclic Nucleotide Second Messenger (GO:0007187),1/50,0.214058720124535,0.311940271634472,0,0,4.26530612244898,6.57499032398412,CCL2
Positive Regulation Of Developmental Growth (GO:0048639),1/50,0.214058720124535,0.311940271634472,0,0,4.26530612244898,6.57499032398412,AGRN
RNA Modification (GO:0009451),1/51,0.217840687742876,0.314095875350193,0,0,4.17978947368421,6.36996268304818,ADARB1
Regulation Of Stress-Activated MAPK Cascade (GO:0032872),1/51,0.217840687742876,0.314095875350193,0,0,4.17978947368421,6.36996268304818,EIF2AK2
Regulation Of Synapse Assembly (GO:0051963),1/51,0.217840687742876,0.314095875350193,0,0,4.17978947368421,6.36996268304818,EPHB3
Regulated Exocytosis (GO:0045055),1/51,0.217840687742876,0.314095875350193,0,0,4.17978947368421,6.36996268304818,OTOF
Sensory Perception (GO:0007600),1/51,0.217840687742876,0.314095875350193,0,0,4.17978947368421,6.36996268304818,CCL2
Sprouting Angiogenesis (GO:0002040),1/52,0.221604645104967,0.316239401201822,0,0,4.09762641898865,6.17455083177755,RNF213
Positive Regulation Of Telomere Maintenance (GO:0032206),1/52,0.221604645104967,0.316239401201822,0,0,4.09762641898865,6.17455083177755,PML
Cellular Response To Ionizing Radiation (GO:0071479),1/52,0.221604645104967,0.316239401201822,0,0,4.09762641898865,6.17455083177755,BRCA2
Positive Regulation Of B Cell Activation (GO:0050871),1/52,0.221604645104967,0.316239401201822,0,0,4.09762641898865,6.17455083177755,CD38
Negative Regulation Of DNA-templated Transcription (GO:0045892),7/1025,0.221645797323271,0.316239401201822,0,0,1.45915101211894,2.19846588256388,ETV7;IFI27;STAT1;ZNF219;CD38;PARP9;PML
Negative Regulation Of Macromolecule Metabolic Process (GO:0010605),2/186,0.224593232878477,0.318197022289773,0,0,2.28029602220167,3.4055408548939,PARP9;PARP14
Regulation Of Cyclin-Dependent Protein Kinase Activity (GO:1904029),1/53,0.225350677076188,0.318197022289773,0,0,4.01862348178138,5.98814090529979,HERC5
mRNA Stabilization (GO:0048255),1/53,0.225350677076188,0.318197022289773,0,0,4.01862348178138,5.98814090529979,IGF2BP3
Protein Homotetramerization (GO:0051289),1/53,0.225350677076188,0.318197022289773,0,0,4.01862348178138,5.98814090529979,GBP5
Positive Regulation Of NIK/NF-kappaB Signaling (GO:1901224),1/53,0.225350677076188,0.318197022289773,0,0,4.01862348178138,5.98814090529979,EIF2AK2
Axonogenesis (GO:0007409),2/188,0.228127724524431,0.319492409136419,0,0,2.25554792953558,3.3333606316001,NEXN;EPHB3
Epidermal Cell Differentiation (GO:0009913),1/54,0.22907886813447,0.319492409136419,0,0,3.94260178748759,5.81016861902901,KRT10
Positive Regulation Of Leukocyte Chemotaxis (GO:0002690),1/54,0.22907886813447,0.319492409136419,0,0,3.94260178748759,5.81016861902901,CXCL10
Negative Regulation Of Protein Ubiquitination (GO:0031397),1/54,0.22907886813447,0.319492409136419,0,0,3.94260178748759,5.81016861902901,DTX3L
Regulation Of Lipid Metabolic Process (GO:0019216),1/54,0.22907886813447,0.319492409136419,0,0,3.94260178748759,5.81016861902901,RNF213
Regulation Of Smooth Muscle Cell Proliferation (GO:0048660),1/54,0.22907886813447,0.319492409136419,0,0,3.94260178748759,5.81016861902901,STAT1
Regulation Of Synaptic Transmission, Glutamatergic (GO:0051966),1/55,0.232789302346206,0.323344815071513,0,0,3.86939571150097,5.6401144441697,CCL2
Response To Peptide Hormone (GO:0043434),1/55,0.232789302346206,0.323344815071513,0,0,3.86939571150097,5.6401144441697,STAT1
Positive Regulation Of Interleukin-1 Beta Production (GO:0032731),1/57,0.240157234640231,0.331553105313031,0,0,3.73082706766917,5.32188089843228,GBP5
Post-Transcriptional Regulation Of Gene Expression (GO:0010608),1/57,0.240157234640231,0.331553105313031,0,0,3.73082706766917,5.32188089843228,PARP9
Endosome To Lysosome Transport (GO:0008333),1/57,0.240157234640231,0.331553105313031,0,0,3.73082706766917,5.32188089843228,DTX3L
Positive Regulation Of Protein Metabolic Process (GO:0051247),2/196,0.242302600632841,0.333229982087752,0,0,2.16165825839,3.06429739700269,SAMD4A;RIGI
Renal System Development (GO:0072001),1/58,0.243814898917578,0.333229982087752,0,0,3.665189289012,5.17285006846245,STAT1
Muscle Organ Development (GO:0007517),1/58,0.243814898917578,0.333229982087752,0,0,3.665189289012,5.17285006846245,CXCL10
Response To Organic Cyclic Compound (GO:0014070),1/58,0.243814898917578,0.333229982087752,0,0,3.665189289012,5.17285006846245,CCL2
Selective Autophagy (GO:0061912),1/58,0.243814898917578,0.333229982087752,0,0,3.665189289012,5.17285006846245,RNF213
Positive Regulation Of Protein Binding (GO:0032092),1/59,0.247455138759275,0.336184072975748,0,0,3.60181488203267,5.03002802527972,DTX3L
Regulation Of Multicellular Organismal Development (GO:2000026),1/59,0.247455138759275,0.336184072975748,0,0,3.60181488203267,5.03002802527972,OAS2
Regulation Of Type I Interferon Production (GO:0032479),1/59,0.247455138759275,0.336184072975748,0,0,3.60181488203267,5.03002802527972,XAF1
Regulation Of Extrinsic Apoptotic Signaling Pathway (GO:2001236),1/60,0.251078036313998,0.339079645081478,0,0,3.54058876003568,4.89306352364077,PML
Negative Regulation Of Peptidase Activity (GO:0010466),1/60,0.251078036313998,0.339079645081478,0,0,3.54058876003568,4.89306352364077,SERPING1
Homophilic Cell Adhesion Via Plasma Membrane Adhesion Molecules (GO:0007156),1/60,0.251078036313998,0.339079645081478,0,0,3.54058876003568,4.89306352364077,NEXN
Positive Regulation Of Interleukin-8 Production (GO:0032757),1/61,0.254683673338579,0.341917844915179,0,0,3.48140350877193,4.7616304673106,RIGI
Positive Regulation Of Organelle Assembly (GO:1902117),1/61,0.254683673338579,0.341917844915179,0,0,3.48140350877193,4.7616304673106,FSCN1
Positive Regulation Of Cell Junction Assembly (GO:1901890),1/61,0.254683673338579,0.341917844915179,0,0,3.48140350877193,4.7616304673106,EPHB3
Protein Modification Process (GO:0036211),5/711,0.255894903130876,0.342869005766713,0,0,1.49410080004981,2.03644213874337,PGAP1;CCL2;EIF2AK2;KRT10;EPHB3
Positive Regulation Of Apoptotic Signaling Pathway (GO:2001235),1/62,0.258272131188966,0.34469979152813,0,0,3.42415875754961,4.63542573698017,PML
Regulation Of T Cell Activation (GO:0050863),1/62,0.258272131188966,0.34469979152813,0,0,3.42415875754961,4.63542573698017,CCL2
Phosphatidylinositol Metabolic Process (GO:0046488),1/63,0.261843490894303,0.348783712480302,0,0,3.36876061120543,4.51416723602791,PGAP1
Positive Regulation Of Interleukin-1 Production (GO:0032732),1/64,0.265397833031411,0.35214265005335,0,0,3.31512113617377,4.39759213274105,GBP5
Regulation Of Secretion By Cell (GO:1903530),1/64,0.265397833031411,0.35214265005335,0,0,3.31512113617377,4.39759213274105,OTOF
Negative Regulation Of Endopeptidase Activity (GO:0010951),1/66,0.272455785176125,0.360805525223529,0,0,3.21279352226721,4.17752773718953,SERPING1
Extrinsic Apoptotic Signaling Pathway (GO:0097191),1/67,0.275959554534678,0.364737240683431,0,0,3.16395534290271,4.07359555892619,IFI27
B Cell Differentiation (GO:0030183),1/68,0.279446625091534,0.365801532269531,0,0,3.11657501963865,3.97345852929614,BLNK
Aerobic Electron Transport Chain (GO:0019646),1/68,0.279446625091534,0.365801532269531,0,0,3.11657501963865,3.97345852929614,UQCRFS1P1
Intermediate Filament Organization (GO:0045109),1/68,0.279446625091534,0.365801532269531,0,0,3.11657501963865,3.97345852929614,KRT10
Cell-Cell Junction Organization (GO:0045216),1/68,0.279446625091534,0.365801532269531,0,0,3.11657501963865,3.97345852929614,FSCN1
Skin Development (GO:0043588),1/68,0.279446625091534,0.365801532269531,0,0,3.11657501963865,3.97345852929614,KRT10
DNA Damage Response (GO:0006974),3/384,0.280436545482595,0.36639410731634,0,0,1.65295063923461,2.10157433395966,DTX3L;FSCN1;PML
Proteasomal Protein Catabolic Process (GO:0010498),2/220,0.284981113750202,0.371302302815912,0,0,1.92133515518251,2.41191421094617,IFI27;PML
Positive Regulation Of Protein Transport (GO:0051222),1/70,0.28637098428324,0.371302302815912,0,0,3.02593440122044,3.78383159972817,CD2AP
Mitochondrial ATP Synthesis Coupled Electron Transport (GO:0042775),1/70,0.28637098428324,0.371302302815912,0,0,3.02593440122044,3.78383159972817,UQCRFS1P1
Regulation Of Actin Filament-Based Process (GO:0032970),1/70,0.28637098428324,0.371302302815912,0,0,3.02593440122044,3.78383159972817,FSCN1
Regulation Of Hydrolase Activity (GO:0051336),1/71,0.289808429357597,0.37433588792023,0,0,2.98255639097744,3.69400096498612,EPHB3
Cell-Cell Junction Assembly (GO:0007043),1/71,0.289808429357597,0.37433588792023,0,0,2.98255639097744,3.69400096498612,FSCN1
Regulation Of Cellular Localization (GO:0060341),1/72,0.293229488388385,0.376614898457398,0,0,2.94040029651594,3.60728231842229,TRIM22
Response To Ionizing Radiation (GO:0010212),1/72,0.293229488388385,0.376614898457398,0,0,2.94040029651594,3.60728231842229,BRCA2
Negative Regulation Of Catabolic Process (GO:0009895),1/72,0.293229488388385,0.376614898457398,0,0,2.94040029651594,3.60728231842229,PML
Positive Regulation Of Secretion By Cell (GO:1903532),1/73,0.296634238686803,0.379558256631143,0,0,2.89941520467836,3.52353003853463,CD2AP
Regulation Of Rho Protein Signal Transduction (GO:0035023),1/73,0.296634238686803,0.379558256631143,0,0,2.89941520467836,3.52353003853463,HEG1
Apoptotic Process (GO:0006915),2/228,0.299187204522494,0.381034488598512,0,0,1.85257013745057,2.23547007730907,IFI27;IFIT2
Positive Regulation Of Lymphocyte Proliferation (GO:0050671),1/74,0.300022757151615,0.381034488598512,0,0,2.85955299206921,3.44260712560385,CD38
Gland Development (GO:0048732),1/74,0.300022757151615,0.381034488598512,0,0,2.85955299206921,3.44260712560385,EPHB3
Negative Regulation Of Neuron Apoptotic Process (GO:0043524),1/74,0.300022757151615,0.381034488598512,0,0,2.85955299206921,3.44260712560385,CCL2
Positive Regulation Of Neurogenesis (GO:0050769),1/75,0.303395120396658,0.383867209134282,0,0,2.82076813655761,3.36438458394582,HAPLN3
Regulation Of Plasma Membrane Bounded Cell Projection Assembly (GO:0120032),1/75,0.303395120396658,0.383867209134282,0,0,2.82076813655761,3.36438458394582,FSCN1
Negative Regulation Of Transcription By RNA Polymerase II (GO:0000122),5/763,0.304051963632961,0.383867209134282,0,0,1.38783380208182,1.6522947749038,ETV7;IFI27;STAT1;ZNF219;PARP9
Negative Regulation Of Intracellular Signal Transduction (GO:1902532),2/231,0.304504633638778,0.383867209134282,0,0,1.82802192697203,2.17364415851316,STAT1;CD2AP
Positive Regulation Of Protein Secretion (GO:0050714),1/76,0.306751404607282,0.385986084764144,0,0,2.78301754385965,3.28874085834244,CD2AP
Cellular Response To Oxygen-Containing Compound (GO:1901701),3/406,0.309267415721829,0.387330640376286,0,0,1.56095413431522,1.83185609047339,CXCL10;CXCL9;CCL2
Positive Regulation Of GTPase Activity (GO:0043547),2/234,0.309815243730519,0.387330640376286,0,0,1.80410858400587,2.11401681791514,CCL2;AGRN
Actomyosin Structure Organization (GO:0031032),1/77,0.310091685697144,0.387330640376286,0,0,2.74626038781163,3.21556131423751,FRMD3
Positive Regulation Of Synaptic Transmission (GO:0050806),1/77,0.310091685697144,0.387330640376286,0,0,2.74626038781163,3.21556131423751,CCL2
Regulation Of Cyclin-Dependent Protein Serine/Threonine Kinase Activity (GO:0000079),1/79,0.316724539977527,0.393453800117802,0,0,2.67557354925776,3.07616802484555,HERC5
Vesicle Fusion (GO:0006906),1/79,0.316724539977527,0.393453800117802,0,0,2.67557354925776,3.07616802484555,SAMD9
Positive Regulation Of Protein Modification By Small Protein Conjugation Or Removal (GO:1903322),1/79,0.316724539977527,0.393453800117802,0,0,2.67557354925776,3.07616802484555,BIRC3
Negative Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071901),1/80,0.320017263171955,0.396590394613418,0,0,2.64157228514324,3.00975552106687,HEG1
Regulation Of Inflammatory Response (GO:0050727),2/240,0.32041247424046,0.396590394613418,0,0,1.75809047023065,2.00096386701202,USP18;BIRC3
Regulation Of Interleukin-8 Production (GO:0032677),1/81,0.323294283156366,0.398710128594289,0,0,2.60842105263158,2.94540890829074,RIGI
Cellular Response To Interleukin-1 (GO:0071347),1/81,0.323294283156366,0.398710128594289,0,0,2.60842105263158,2.94540890829074,CCL2
Cellular Response To Organic Substance (GO:0071310),1/82,0.32655567396506,0.40200536036854,0,0,2.57608836907083,2.88304173379209,CCL2
Positive Regulation Of Programmed Cell Death (GO:0043068),2/245,0.329215043882216,0.403090733643288,0,0,1.72147797916119,1.91263797426454,GBP5;IFIT2
Positive Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032436),1/83,0.329801509344508,0.403090733643288,0,0,2.54454428754814,2.82257211840961,RNF144A
Positive Regulation Of Ubiquitin-Dependent Protein Catabolic Process (GO:2000060),1/83,0.329801509344508,0.403090733643288,0,0,2.54454428754814,2.82257211840961,RNF144A
Regulation Of NIK/NF-kappaB Signaling (GO:1901222),1/83,0.329801509344508,0.403090733643288,0,0,2.54454428754814,2.82257211840961,EIF2AK2
Regulation Of Interleukin-1 Beta Production (GO:0032651),1/84,0.333031862791669,0.404862264570265,0,0,2.5137603043754,2.76392246389309,GBP5
Positive Regulation Of Protein Ubiquitination (GO:0031398),1/84,0.333031862791669,0.404862264570265,0,0,2.5137603043754,2.76392246389309,BIRC3
Ribosomal Small Subunit Biogenesis (GO:0042274),1/84,0.333031862791669,0.404862264570265,0,0,2.5137603043754,2.76392246389309,IGF2BP3
Regulation Of Osteoblast Differentiation (GO:0045667),1/85,0.336246807353203,0.405159580591669,0,0,2.48370927318296,2.70701918392176,IFITM1
Nuclear-Transcribed mRNA Catabolic Process (GO:0000956),1/85,0.336246807353203,0.405159580591669,0,0,2.48370927318296,2.70701918392176,SAMD4A
Positive Regulation Of Amide Metabolic Process (GO:0034250),1/85,0.336246807353203,0.405159580591669,0,0,2.48370927318296,2.70701918392176,SAMD4A
Response To Interleukin-1 (GO:0070555),1/85,0.336246807353203,0.405159580591669,0,0,2.48370927318296,2.70701918392176,CCL2
Defense Response To Gram-positive Bacterium (GO:0050830),1/85,0.336246807353203,0.405159580591669,0,0,2.48370927318296,2.70701918392176,GBP4
Phosphorylation (GO:0016310),3/429,0.339530371150944,0.408394555775915,0,0,1.47493563531728,1.59321349312485,CCL2;EIF2AK2;EPHB3
Regulation Of Double-Strand Break Repair (GO:2000779),1/88,0.345799913228033,0.413746562844769,0,0,2.39770114942529,2.54610675816232,PML
Negative Regulation Of Neuron Death (GO:1901215),1/88,0.345799913228033,0.413746562844769,0,0,2.39770114942529,2.54610675816232,CCL2
Negative Regulation Of Protein Kinase Activity (GO:0006469),1/88,0.345799913228033,0.413746562844769,0,0,2.39770114942529,2.54610675816232,ADARB1
Positive Regulation Of Proteasomal Protein Catabolic Process (GO:1901800),1/90,0.352092930362786,0.420538316125079,0,0,2.34358367829687,2.44637356664389,RNF144A
Lymphocyte Differentiation (GO:0030098),1/91,0.355216937016028,0.422052179520786,0,0,2.3174269005848,2.39859845312484,BLNK
rRNA Metabolic Process (GO:0016072),1/91,0.355216937016028,0.422052179520786,0,0,2.3174269005848,2.39859845312484,IGF2BP3
Regulation Of Actin Cytoskeleton Organization (GO:0032956),1/91,0.355216937016028,0.422052179520786,0,0,2.3174269005848,2.39859845312484,FSCN1
B Cell Activation (GO:0042113),1/92,0.358326036827566,0.425005838463305,0,0,2.29184499710815,2.35214799892276,BLNK
Regulation Of Endothelial Cell Proliferation (GO:0001936),1/93,0.361420300149921,0.427931674830288,0,0,2.26681922196796,2.30697304911209,STAT1
Cell Junction Assembly (GO:0034329),1/95,0.367564597279795,0.434452435606274,0,0,2.21836506159015,2.22026442767441,FSCN1
Regulation Of Protein Localization (GO:0032880),1/97,0.373650384955548,0.440120142555585,0,0,2.1719298245614,2.13812312511658,TRIM22
Monocarboxylic Acid Metabolic Process (GO:0032787),1/97,0.373650384955548,0.440120142555585,0,0,2.1719298245614,2.13812312511658,HYI
Negative Regulation Of Nucleic Acid-Templated Transcription (GO:1903507),3/456,0.374965540604922,0.440907756366478,0,0,1.38510289824112,1.35867672636252,ZNF219;CD38;PML
Axon Development (GO:0061564),1/99,0.379678214520859,0.445680795702627,0,0,2.12738990332975,2.06023073332514,EPHB3
Plasma Membrane Bounded Cell Projection Assembly (GO:0120031),2/275,0.381286113009873,0.446121924667798,0,0,1.5299664874133,1.47520169332182,FSCN1;CD2AP
Regulation Of Transcription By RNA Polymerase II (GO:0006357),11/2028,0.381712430951063,0.446121924667798,0,0,1.14763918457814,1.10527724287379,ETV7;BATF2;CXCL10;IFI27;STAT1;SP140;ZNF219;NCOA7;PARP9;AGRN;RIGI
Regulation Of Organelle Organization (GO:0033043),1/100,0.382670565880735,0.446121924667798,0,0,2.10579479000532,2.02278604662789,NEXN
ncRNA Processing (GO:0034470),1/100,0.382670565880735,0.446121924667798,0,0,2.10579479000532,2.02278604662789,IGF2BP3
rRNA Processing (GO:0006364),1/101,0.385648632178026,0.448826565094563,0,0,2.08463157894737,1.98629659598169,IGF2BP3
Positive Regulation Of Stress-Activated MAPK Cascade (GO:0032874),1/105,0.397419391194843,0.4593898725337,0,0,2.00404858299595,1.84926219301671,EIF2AK2
Intrinsic Apoptotic Signaling Pathway (GO:0097193),1/105,0.397419391194843,0.4593898725337,0,0,2.00404858299595,1.84926219301671,PML
Regulation Of Neuron Apoptotic Process (GO:0043523),1/105,0.397419391194843,0.4593898725337,0,0,2.00404858299595,1.84926219301671,CCL2
Lysosomal Transport (GO:0007041),1/105,0.397419391194843,0.4593898725337,0,0,2.00404858299595,1.84926219301671,DTX3L
Regulation Of G1/S Transition Of Mitotic Cell Cycle (GO:2000045),1/106,0.400327037858707,0.461967918476545,0,0,1.98486215538847,1.8170886473975,CCL2
Regulation Of Cellular Response To Stress (GO:0080135),1/107,0.403220799644778,0.462957214406967,0,0,1.96603773584906,1.78569501542377,BRCA2
Positive Regulation Of T Cell Activation (GO:0050870),1/107,0.403220799644778,0.462957214406967,0,0,1.96603773584906,1.78569501542377,CCL2
Positive Regulation Of Autophagy (GO:0010508),1/107,0.403220799644778,0.462957214406967,0,0,1.96603773584906,1.78569501542377,TRIM22
Positive Regulation Of Translation (GO:0045727),1/108,0.406100742126499,0.463228748383849,0,0,1.94756517461879,1.75505618017298,SAMD4A
Positive Regulation Of DNA Metabolic Process (GO:0051054),1/108,0.406100742126499,0.463228748383849,0,0,1.94756517461879,1.75505618017298,PML
Response To Tumor Necrosis Factor (GO:0034612),1/108,0.406100742126499,0.463228748383849,0,0,1.94756517461879,1.75505618017298,CCL2
Positive Regulation Of Gene Expression (GO:0010628),3/480,0.406174181134225,0.463228748383849,0,0,1.31378913910868,1.18368879665583,SAMD4A;EIF2AK2;RIGI
Regulation Of Proteasomal Ubiquitin-Dependent Protein Catabolic Process (GO:0032434),1/109,0.40896693054849,0.464859077723451,0,0,1.92943469785575,1.72514804407533,RNF144A
Cell-Matrix Adhesion (GO:0007160),1/109,0.40896693054849,0.464859077723451,0,0,1.92943469785575,1.72514804407533,SIGLEC1
RNA Metabolic Process (GO:0016070),1/111,0.414658305198867,0.469762398913002,0,0,1.89416267942584,1.66743227586511,ADARB1
Cytoskeleton Organization (GO:0007010),1/111,0.414658305198867,0.469762398913002,0,0,1.89416267942584,1.66743227586511,CCL2
Gene Expression (GO:0010467),2/296,0.416738945013361,0.470617899393329,0,0,1.41916341004487,1.24218704055658,IGF2BP3;ADARB1
Protein Deubiquitination (GO:0016579),1/112,0.417483620429566,0.470617899393329,0,0,1.87700331910858,1.6395811091445,USP18
Regulation Of Protein Serine/Threonine Kinase Activity (GO:0071900),1/112,0.417483620429566,0.470617899393329,0,0,1.87700331910858,1.6395811091445,HERC5
Regulation Of Protein Ubiquitination (GO:0031396),1/113,0.420295439837323,0.473005759024843,0,0,1.86015037593985,1.61237348493879,BIRC3
Protein Modification By Small Protein Removal (GO:0070646),1/114,0.423093827175321,0.47537065919863,0,0,1.84359571495109,1.5857897069044,USP18
Endoplasmic Reticulum To Golgi Vesicle-Mediated Transport (GO:0006888),1/115,0.425878846004127,0.47771278449805,0,0,1.82733148661127,1.55981083712826,PGAP1
Protein Phosphorylation (GO:0006468),3/500,0.431847798776462,0.483612805854757,0,0,1.25962224962679,1.05768221856858,CCL2;EIF2AK2;EPHB3
Regulation Of Small GTPase Mediated Signal Transduction (GO:0051056),1/118,0.434154321630298,0.484604332818107,0,0,1.78020692757535,1.48532495746401,CD2AP
Ribonucleoprotein Complex Biogenesis (GO:0022613),1/118,0.434154321630298,0.484604332818107,0,0,1.78020692757535,1.48532495746401,IGF2BP3
Regulation Of Protein-Containing Complex Assembly (GO:0043254),1/119,0.436886495259523,0.486857172821887,0,0,1.7650312221231,1.4615903265578,EIF2AK2
Positive Regulation Of MAPK Cascade (GO:0043410),2/310,0.439814638577483,0.489320690880659,0,0,1.35368886432716,1.11192262789797,CCL2;EIF2AK2
Potassium Ion Transport (GO:0006813),1/122,0.445004929704951,0.493485141558986,0,0,1.72100913440626,1.39344932626127,KCNK13
Protein Localization To Nucleus (GO:0034504),1/122,0.445004929704951,0.493485141558986,0,0,1.72100913440626,1.39344932626127,PML
Modulation Of Chemical Synaptic Transmission (GO:0050804),1/123,0.447685250521208,0.495388037126376,0,0,1.70681622088007,1.37170821797558,OTOF
Supramolecular Fiber Organization (GO:0097435),2/316,0.449554405246032,0.495388037126376,0,0,1.32741563897547,1.06126667599747,KRT10;CD2AP
Negative Regulation Of Growth (GO:0045926),1/124,0.450352761023978,0.495388037126376,0,0,1.6928540864356,1.35043048548742,PML
Protein Dephosphorylation (GO:0006470),1/124,0.450352761023978,0.495388037126376,0,0,1.6928540864356,1.35043048548742,PPM1K
Positive Regulation Of Defense Response (GO:0031349),1/124,0.450352761023978,0.495388037126376,0,0,1.6928540864356,1.35043048548742,GBP5
Negative Regulation Of Cell Growth (GO:0030308),1/125,0.453007521802702,0.497505845200391,0,0,1.67911714770798,1.32960311914194,PML
Proteasome-Mediated Ubiquitin-Dependent Protein Catabolic Process (GO:0043161),2/319,0.454389188062126,0.498220942537572,0,0,1.31465199006645,1.03699907488717,IFI27;PML
Cellular Response To Starvation (GO:0009267),1/126,0.455649593125126,0.498800999215628,0,0,1.6656,1.30921356837768,EIF2AK2
Regulation Of Anatomical Structure Morphogenesis (GO:0022603),1/127,0.458279035033115,0.500875483802219,0,0,1.65229741019215,1.28924972182696,EPHB3
Positive Regulation Of Intracellular Signal Transduction (GO:1902533),3/525,0.46337833065387,0.504158187694094,0,0,1.19775058707206,0.921323441531904,EIF2AK2;TRIM22;BIRC3
Protein Homooligomerization (GO:0051260),1/129,0.463500269331667,0.504158187694094,0,0,1.62631578947368,1.25055278254875,GBP5
Regulation Of DNA Repair (GO:0006282),1/129,0.463500269331667,0.504158187694094,0,0,1.62631578947368,1.25055278254875,PML
Synapse Organization (GO:0050808),1/131,0.468671699182142,0.508246397152528,0,0,1.60113360323887,1.21342351617286,AGRN
Protein-Containing Complex Assembly (GO:0065003),2/328,0.468749243121613,0.508246397152528,0,0,1.27777052604099,0.968150520816145,PML;CD2AP
Positive Regulation Of Transcription By RNA Polymerase II (GO:0045944),5/938,0.470846278086327,0.508520441843213,0,0,1.11721611721612,0.841513558889016,CXCL10;STAT1;NCOA7;AGRN;RIGI
Epithelial Cell Differentiation (GO:0030855),1/132,0.471238884523329,0.508520441843213,0,0,1.58883085576537,1.19542065048922,KRT10
Circulatory System Development (GO:0072359),1/132,0.471238884523329,0.508520441843213,0,0,1.58883085576537,1.19542065048922,HEG1
Non-Membrane-Bounded Organelle Assembly (GO:0140694),1/135,0.478867021707057,0.515935716910289,0,0,1.55302435192459,1.14354204983655,RNF213
Potassium Ion Transmembrane Transport (GO:0071805),1/137,0.483891841506333,0.519707458121762,0,0,1.53003095975232,1.11064008725076,KCNK13
Protein Localization To Organelle (GO:0033365),1/137,0.483891841506333,0.519707458121762,0,0,1.53003095975232,1.11064008725076,GBP5
Intracellular Calcium Ion Homeostasis (GO:0006874),1/139,0.488868711167274,0.524227139962391,0,0,1.50770404271548,1.07900545011531,PML
Negative Regulation Of Wnt Signaling Pathway (GO:0030178),1/140,0.491339306370896,0.526049304466171,0,0,1.4967815221507,1.06364339145528,RNF213
Regulation Of Cell Adhesion (GO:0030155),1/144,0.501104064629769,0.535662965638719,0,0,1.45461906514538,1.00505665790444,EPHB3
Neuron Projection Morphogenesis (GO:0048812),1/146,0.505916646990971,0.539961116193806,0,0,1.43441016333938,0.977383206000561,EPHB3
Cellular Response To Organic Cyclic Compound (GO:0071407),1/152,0.520080452788294,0.554210732502526,0,0,1.37699546880446,0.90024075455835,CCL2
Positive Regulation Of Macromolecule Metabolic Process (GO:0010604),2/364,0.523897719479328,0.557407558010767,0,0,1.14858351945457,0.74251193005739,DTX3L;RIGI
Positive Regulation Of Response To External Stimulus (GO:0032103),1/155,0.527010921346818,0.558107839066041,0,0,1.34996582365003,0.864699018385904,GBP5
Cellular Response To Growth Factor Stimulus (GO:0071363),1/155,0.527010921346818,0.558107839066041,0,0,1.34996582365003,0.864699018385904,CCL2
Ribosome Biogenesis (GO:0042254),1/155,0.527010921346818,0.558107839066041,0,0,1.34996582365003,0.864699018385904,IGF2BP3
Peptide Biosynthetic Process (GO:0043043),1/158,0.533842334996848,0.564465848787364,0,0,1.3239691585652,0.830995513264038,IGF2BP3
Regulation Of Macromolecule Metabolic Process (GO:0060255),1/162,0.542799219929216,0.572162392568354,0,0,1.29081399150049,0.788707728366851,IGF2BP3
Mitochondrion Organization (GO:0007005),1/162,0.542799219929216,0.572162392568354,0,0,1.29081399150049,0.788707728366851,IFIT2
Membrane Organization (GO:0061024),1/167,0.553756159460729,0.582811266592927,0,0,1.25161699429296,0.73974423661762,OTOF
Heart Development (GO:0007507),1/171,0.562334276093436,0.590927544369374,0,0,1.22191950464396,0.703408726237421,HEG1
Cell-Cell Adhesion Via Plasma-Membrane Adhesion Molecules (GO:0098742),1/172,0.564453182310229,0.592241646670117,0,0,1.21471221914435,0.694691288756235,NEXN
Regulation Of Neuron Projection Development (GO:0010975),1/174,0.568660586492961,0.594825950902147,0,0,1.20054761180408,0.677674949239004,EPHB3
Positive Regulation Of Cellular Biosynthetic Process (GO:0031328),1/174,0.568660586492961,0.594825950902147,0,0,1.20054761180408,0.677674949239004,SAMD4A
Negative Regulation Of Cytokine Production (GO:0001818),1/178,0.57695510172883,0.602577916353847,0,0,1.17317870948558,0.645237530756465,XAF1
Positive Regulation Of ERK1 And ERK2 Cascade (GO:0070374),1/179,0.579003945966316,0.603793105732458,0,0,1.1665286812537,0.637444915765492,CCL2
RNA Processing (GO:0006396),1/183,0.587101588505191,0.610370858781311,0,0,1.14065934065934,0.607466584421751,ADARB1
Macromolecule Biosynthetic Process (GO:0009059),1/183,0.587101588505191,0.610370858781311,0,0,1.14065934065934,0.607466584421751,IGF2BP3
Transcription By RNA Polymerase II (GO:0006366),1/192,0.60476204523592,0.625869066541575,0,0,1.08641499035547,0.546380057246775,ETV7
Neuron Projection Development (GO:0031175),1/192,0.60476204523592,0.625869066541575,0,0,1.08641499035547,0.546380057246775,EPHB3
Protein Localization To Membrane (GO:0072657),1/192,0.60476204523592,0.625869066541575,0,0,1.08641499035547,0.546380057246775,AGRN
Regulation Of Cell Differentiation (GO:0045595),1/193,0.606677570319648,0.62690015599697,0,0,1.08070175438596,0.540089147099855,EIF2AK2
Golgi Vesicle Transport (GO:0048193),1/197,0.61424823166312,0.633762925861192,0,0,1.05843179377014,0.515833240281723,PGAP1
DNA-templated Transcription (GO:0006351),1/199,0.617979304296652,0.636649373912865,0,0,1.04763423710792,0.504226683378221,ETV7
Regulation Of MAPK Cascade (GO:0043408),1/204,0.627151469465648,0.64512413601142,0,0,1.02157116930257,0.476631589263578,EIF2AK2
Regulation Of Cell Growth (GO:0001558),1/227,0.666613880922749,0.684684739140534,0,0,0.91653469958081,0.371695413872479,PML
Chromatin Remodeling (GO:0006338),1/228,0.668232499187388,0.685315134504961,0,0,0.912450730350104,0.367826329372433,DTX3L
Negative Regulation Of Multicellular Organismal Process (GO:0051241),1/231,0.67304183888299,0.689211012189488,0,0,0.900411899313501,0.356516095805054,BRCA2
Positive Regulation Of Developmental Process (GO:0051094),1/233,0.676209670525794,0.690952832472889,0,0,0.892558983666062,0.349215565603209,KRT10
Positive Regulation Of Cell Population Proliferation (GO:0008284),2/483,0.677756964071409,0.690952832472889,0,0,0.859158667669306,0.334183953118055,STAT1;IL31RA
Translation (GO:0006412),1/234,0.67778217730845,0.690952832472889,0,0,0.888683081093291,0.345634902041417,IGF2BP3
Regulation Of Autophagy (GO:0010506),1/241,0.688580105934538,0.700912883951276,0,0,0.862456140350877,0.321802756396345,TRIM22
Regulation Of ERK1 And ERK2 Cascade (GO:0070372),1/244,0.693097438635542,0.704459691727928,0,0,0.851678579163959,0.312212324161764,CCL2
Positive Regulation Of Apoptotic Process (GO:0043065),1/270,0.729627346549257,0.740484896349097,0,0,0.768342790060654,0.242198058737535,IFIT2
Monoatomic Cation Transmembrane Transport (GO:0098655),1/281,0.743754831189108,0.753701032497729,0,0,0.737744360902256,0.218404663526407,KCNK13
Positive Regulation Of Cell Differentiation (GO:0045597),1/283,0.746243814962308,0.755101308314976,0,0,0.732437476670399,0.214386575297312,IFITM1
Inorganic Cation Transmembrane Transport (GO:0098662),1/284,0.747479319996682,0.75523095738924,0,0,0.729812162916124,0.21241083722134,KCNK13
DNA Metabolic Process (GO:0006259),1/288,0.752362091286047,0.759039861327048,0,0,0.719493856592701,0.204723031101543,FSCN1
Protein Localization (GO:0008104),1/351,0.818016457679581,0.824057938164659,0,0,0.58809022556391,0.118131343887171,HEG1
Positive Regulation Of Multicellular Organismal Process (GO:0051240),1/387,0.847457610370876,0.852457360284568,0,0,0.532260703572403,0.0880968419941957,EIF2AK2
Vesicle-Mediated Transport (GO:0016192),1/411,0.864413051779541,0.868232255248375,0,0,0.500487804878049,0.0729233530065265,DTX3L
Organelle Organization (GO:0006996),1/418,0.868997161585773,0.871553035590437,0,0,0.491909630190584,0.0690716973358487,CCL2
Nervous System Development (GO:0007399),1/433,0.878310121156031,0.87959985701676,0,0,0.474463937621832,0.0615643218509787,IGF2BP3
Positive Regulation Of Cellular Process (GO:0048522),1/594,0.945052030848547,0.945052030848547,0,0,0.342788674891275,0.0193728027088198,IL31RA
